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Many important research questions for genomics investigators revolve around estimates of
treatment or exposure effects on an outcome of interest. Large-scale observational studies are
increasingly common, and these data are often used in estimation of such effects. This research
aims to delineate exposure effect estimation methods that yield reproducible and interpretable
estimates in the context of observational genomics studies, by appropriately adjusting for con-
founding and accounting for sampling design.
In Chapter 2, we compare the performance of a common regression approach for exposure ef-
fect estimation to inverse probability weighting (IPW) and the parametric g-formula for genomics
data. Both IPW and the parametric g-formula are shown to be valid alternatives to regression that
adequately adjust for confounding in a wider variety of circumstances. The three methods are
compared using simulation studies and a study estimating the effect of current smoking on gene
expression in adipose tissue.
Variance of the IPW average treatment effect estimator is often estimated assuming the
weights are known and using the “robust” (Huber-White) sandwich estimator, resulting in conser-
vative standard error (SE) estimation. It is shown in Chapter 3 that using such an approach when
estimating the variance of the IPW average treatment effect in the treated (ATT) estimator from
Chapter 2 may result in conservative or anti-conservative SEs. Thus, confidence intervals and
hypothesis tests of the ATT using the robust SE estimate are not valid in general. Instead, stacked
estimating equations accounting for weight estimation are used to compute a consistent, closed-
form variance estimator for the IPW ATT estimator. These variance estimators are compared via
iii
simulation studies and a study estimating the effect of current smoking on gene expression in
adipose tissue.
In Chapter 4, inference on exposure effects from two-phase outcome-dependent sampling
data is considered. An existing IPW estimator for this sampling design is extended to allow for
a multinomial outcome, adjusting for confounding and biased sampling. IPW is shown to be a
valid alternative to common regression approaches in this setting. The methods are compared
in simulation studies and applied to a study investigating heterogeneity in exposure effects on
incidence of breast cancer subtypes.
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“Forty-two!” yelled Loonquawl. “Is that all you’ve got to show for seven and a half million years’
work?”
“I checked it very thoroughly,” said the computer, “and that quite definitely is the answer. I think
the problem, to be quite honest with you, is that you’ve never actually known what the question
is.”
Douglas Adams, The Hitchhiker’s Guide to the Galaxy
v
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CHAPTER 1: LITERATURE REVIEW
1.1 Introduction
Genomics researchers are often interested in answering questions pertaining to exposure
effects on gene expression. The term “exposure effect” implies a causal relationship of some
exposure of interest on an outcome, more than merely an association. Identifying these causal
relationships can add great value to collective medical and public health knowledge, advancing
research and leading to improvements in health policy. These researchers will often use large-
scale, observational data sets including both molecular measurements (e.g. RNA gene expression)
and lifestyle or environmental factors to estimate exposure effects. Data sets like these are becom-
ing increasingly common and interest is growing in the field of genetic epidemiology (Pingault
et al., 2018). For instance, etiologic heterogeneity has been a subject of increasing attention in
recent years as the technology and data to study it has become available. The concept of etiologic
heterogeneity refers to the idea that the various subtypes of a disease may have different risk fac-
tors, or that a given risk factor may have varying effects across subtypes of a disease. This is of
particular relevance to cancer research, where researchers may ask questions about whether cer-
tain lifestyle factors have the same effect on a person’s likelihood of developing different cancer
subtypes (Zabor and Begg, 2017).
Since the data sets used for analyses of exposure effects are often generated by observational
studies, and therefore individuals are not randomized to the exposure of interest, confounding is
expected in general. Specifically, one or more variables may influence both the exposure and the
outcome, thus inducing a non-causal association between exposure and outcome. If confounding
is not properly adjusted for in the analysis, this spurious association can lead to biased exposure
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effect estimates and invalid inference (Austin, 2011; Hernán and Robins, 2020). Confounding
may not be a concern when estimating exposure effects if the data were instead sourced from
a randomized trial, but there are several reasons why researchers turn to observational studies.
Generally, observational studies take less time and money than randomized trials. Observational
studies also provide a unique opportunity to examine certain exposures, to which individuals
cannot ethically be randomized (e.g., smoking cigarettes). For these reasons of feasibility and
convenience, it is worth investing the effort in developing methods for appropriate confounding
adjustment with this type of study.
The causal methods assessed and extended in the following chapters use the observed data to
estimate associational measures between exposure A and outcome Y that, under certain assump-
tions, may equal their causal counterparts. The sufficient assumptions for each method are also
discussed extensively. Several regression-based methods are commonly employed to estimate
exposure effects from observational studies in practice, and their performance is compared to the
causal methods in the chapters that follow.
1.2 Motivating Examples
1.2.1 Metabolic Syndrome in Men Data
The first of two motivating data sets for this work comes from the Metabolic Syndrome in
Men (METSIM) study, conducted in 2005-2010 (Laakso et al., 2017). From this population-
based study of Finnish men, we have a cross-sectional sample of 770 individuals. Each partici-
pant provided an adipose tissue sample, as well as past and current lifestyle factor information
through answering questions about smoking, diet, exercise, etc. Gene expression was measured
via microarray for each of over 18,000 genes in each individual (Civelek et al., 2017). A driving
purpose of this study was to use both genetic and non-genetic information to investigate risk fac-
tors for cardiovascular diseases and type II diabetes. Specifically, the study investigators aimed to
generate hypotheses about potential mechanisms through which environmental exposures may in-
2
fluence the development of these chronic diseases. These data were used to investigate questions
of this nature and to illustrate the methods discussed in Chapters 2 and 3.
1.2.2 Carolina Breast Cancer Study Data
The Carolina Breast Cancer Study (CBCS) furnished the second motivating data set for this
work. CBCS was conducted in three phases, Phases I (1993-1996) and II (1996-2001) being
case-control studies and Phase III (2008-2013) collecting information on cases only. For the first
two phases, cases were sampled from the North Carolina Central Cancer Registry and controls
were sampled from DMV and Medicare records; cases were approximately frequency matched
to controls on age and race (Weinberg and Wacholder, 1990; Weinberg and Sandler, 1991). The
analysis data set for Phases I and II contained 1231 cases (invasive only) and 1455 controls, all
female (Benefield et al., 2019). Each case contributed a breast tumor sample, for which cancer
subtype was determined using the microarray gene expression data from the sample. Addition-
ally, all participants contributed past and current (with respect to time of diagnosis or study re-
cruitment for cases and controls, respectively) lifestyle factor information via surveys. One of the
original goals of the CBCS was to study etiologic heterogeneity of breast cancer subtypes (New-
man et al., 1995), and this manuscript uses the data from Phases I and II for this purpose and to
illustrate the methods assessed in Chapter 4.
1.3 Regression-Based and Other Bias Adjustment Methods
1.3.1 Confounding Adjustment Methods for Various Study Designs
The presence of confounding in observational datasets is widely acknowledged, and at-
tempts to adjust for this confounding when estimating exposure effects are widely practiced.
Across many fields, in cross-sectional, outcome-dependent sampling, and other study designs,
regression-based adjustment methods for confounding are common (McNamee, 2005; Kurth
et al., 2006; Vanderweele and Robinson, 2014). In analysis of microarray data, for example,
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including confounders as covariates in the outcome regression model is often the adjustment
method of choice (Smyth, 2005; Hummel et al., 2008).
Other statistical approaches to confounding adjustment that have been applied to genomics
data include sample matching (Heller et al., 2008), the combination of targeted minimum loss-
based estimation (TMLE) and empirical Bayes shrinkage estimation (Hejazi et al., 2017), and
TMLE for differential methylation controlling for observed methylation at neighboring genomic
sites (Hejazi et al., 2018).
1.3.2 Other Bias Adjustment Methods for Gene Expression Data
The issue of structural technical variation and how to adjust for it arises when working with
gene expression data. Here structural refers to variation in the measurements across samples
that is common across many genes. This source of bias is characterized by induced sample cor-
relations from technical sources and can also referred to as a “batch effect”. Several statistical
methods have been proposed to adjust for this bias (Gagnon-Bartsch and Speed, 2012; Leek and
Storey, 2007; Stegle et al., 2012). In particular, these methods address sample non-independence
with a focus on estimation of latent factors, orthogonal to the biological condition of the samples,
to be included in a linear model framework as regressors to account for the technical variation in
the measurements.
There may also be bias in a study sample from genetic relatedness of or repeated measures
on individuals. Unlike the structural technical variation described above, this source of bias is
characterized by sample correlations arising from biological sources. This type of sample non-
independence can be addressed by explicit modeling of the known sample correlation structure
as in a random effects framework (Cui et al., 2016), and several options exist in software for this
purpose (Smyth et al., 2005; Van De Wiel et al., 2012; Sun et al., 2017).
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1.3.3 Regression-Based Methods for Etiologic Heterogeneity
In studying etiologic heterogeneity, a distinction must be made between genetic and envi-
ronmental risk factors because they may not suffer from the same potential biases. Geneticists
performing genome-wide association studies (GWAS) often rely on the assumption that the in-
dividuals in their study are not related, or that approaches based on mixed models sufficiently
capture relatedness due to ancestry differences in the population under study (Sul et al., 2018).
In interpreting genetic associations from GWAS, it is sometimes assumed that genetic risk fac-
tors are not influenced by other variables. One might assume no confounding of the relationship
between the genetic risk factors and disease subtypes: that other variables that may influence
outcomes do not influence an individual’s chance of possessing a certain set of alleles. Envi-
ronmental risk factors, however, are often influenced by many other factors which also affect
disease. Under these assumptions, environmental but not genetic risk factor effects may be prone
to confounding when estimated using observational study data. Thus, regression methods for
estimating genetic effects on disease subtype, sometimes with adjustment for principal compo-
nents of ancestry, can yield consistent estimates; several recent instances of analyses like these
can be found in Zhang et al. (2019a,b); Ahearn et al. (2019). On the other hand, regression may
not adequately adjust for confounding when estimating environmental exposure effects on dis-
ease subtype. Benefield et al. (2019) use a multinomial logistic regression approach where they
include the potential confounders in the regression model as predictors. Zabor and Begg (2017)
compare regression-based methods for studying etiologic heterogeneity from Chatterjee (2004),
Rosner et al. (2013), and Wang et al. (2015), which incorporate confounding variables similarly
for bias adjustment. Note that these methods involve strong assumptions with respect to con-
founding adjustment, particularly that the confounders and exposure do not interact to influence
the outcome.
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1.4 Causal Inference in Observational Studies with Binary Exposure
The causal methods explored in this section are presented in the context of the potential out-
comes framework, which was proposed by Neyman (1935) and popularized by Rubin (1974).
Consider an outcome variable Y and a binary exposure variable A. The aforementioned con-
founding variables are referred to collectively as a set L of measured variables that influence
both A and Y . Let Y a denote the outcome had, possibly counter to fact, the exposure level been
a, where a “ 0, 1. These Y a are often referred to as counterfactuals or potential outcomes, and
only at most one of Y 1, Y 0 are observed for any given individual. The target estimands of inter-
est herein are formulated using both potential outcomes, and thus cannot generally be identified
without further assumptions; this is commonly referred to as the fundamental problem of causal
inference (Holland, 1986). Three common assumptions that will be relied upon extensively
in this section are causal consistency (no different versions of treatment/exposure), positivity
(P pA “ a|L “ lq ą 0 for all l where dFLplq ą 0 and FL is the CDF of L), and conditional
exchangeability (Y a K A|L for a “ 0, 1) (Naimi et al., 2017; Hernán and Robins, 2020).
The methods outlined in the subsections below specifically address confounding, but there
may be other possible sources of bias when estimating exposure effects with observational data.
For example, while the methods here implicitly assume no systematic measurement error, meth-
ods have been developed and discussed elsewhere to account for bias from this source (Hernán
and Cole, 2009; Kuroki and Pearl, 2014; Suzuki et al., 2016; Hernán and Robins, 2020). In ad-
dition, the methods described here assume the data constitute a random sample from the target
population. Non-random sampling from the population of interest may also introduce bias, and
adjustment for biased sampling has been discussed elsewhere as well (Stuart et al., 2011; Lesko
et al., 2017; Buchanan et al., 2018).
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1.4.1 Target Estimands
The research question plays a key role in determining the quantity of interest to be estimated.
This quantity is referred to as the target estimand, and those relevant to this manuscript can be
constructed using the following counterfactual means: the mean in the population, µa “ ErY as,
and the mean in the treated, µA“1a “ ErY
a|A “ 1s, where a “ 0, 1. Two popular target estimands
in causal inference are the average treatment effect (ATE) and the average treatment effect in the
treated (ATT), defined as ATE “ µ1 ´ µ0 and ATT “ µA“11 ´ µ
A“1
0 .
These estimands differ in their assumed target population, with the ATE targeting the gen-
eral study population and the ATT targeting only the treated or exposed individuals. Indeed,
Pirracchio et al. (2016) explore how the ATE and ATT can be very different when estimated with
propensity score methods. They go on to stress the importance of first establishing which esti-
mand is best suited to answer a researcher’s question of interest, before choosing a method of
estimation. For example, the ATT was the preferred target of inference for Were et al. (2017)
when analyzing a sample of pregnant women and estimating the effect of health insurance on
institutional delivery and access to skilled birth attendants, for those who were enrolled in in-
surance. The ATT can be useful across disciplines to target treatment effects among only those
individuals or units who ultimately receive the treatment. Other contexts in which the ATT can be
the preferred target of inference include, but are not limited to, health behavior and policy (Rawat
et al., 2010; Austin, 2011; Boulay et al., 2014; Moodie et al., 2018), pharmacoepidemiology
(Brookhart et al., 2013; Taylor et al., 2013; Nduka et al., 2016), ecology and environmental man-
agement (Gross and Rosenheim, 2011; Tamini, 2011; Ramsey et al., 2019), criminology (Apel
and Sweeten, 2010; Morris, 2016; Widdowson et al., 2016), and economics and public policy
(Heckman and Vytlacil, 2001; Addai et al., 2014; Marcus, 2014; Abdia et al., 2017; Jawid and
Khadjavi, 2019).
The ATE, ATT, and other target estimands constructed with the counterfactual means de-
fined above are all considered marginal, as opposed to conditional, causal effects. A marginal
effect is often desirable because it provides a single effect estimate that characterizes the popula-
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tion of interest, as compared to having a variety of exposure effects across combinations of the
covariates used for conditioning. If the researcher was specifically interested in effect measure
modification, which we do not consider in this manuscript, then conditional effects may be of
interest (Snowden et al., 2010; Naimi et al., 2017).
1.4.2 Inverse Probability Weighting
Inverse probability weighting (IPW) is often and increasingly used for estimation of treat-
ment effects from observational data, where confounding is expected in general (Austin and
Stuart, 2015). If a sufficient set of confounding variables are identified, the propensity score can
be estimated and used to produce the weights needed to get consistent point estimates of several
target estimands such as the ATE or the ATT. Generally, IPW uses these weights to construct a
“pseudo-population” in which there is no longer confounding of the effect of an exposure on the
outcome of interest (Robins et al., 2000).
The propensity score was described by Rosenbaum and Rubin (1983) and is defined as
P pA “ 1|Lq, where A is binary treatment and L is the set of J confounding variables, and repre-
sents the probability that an individual receives treatment given their confounding variable values.
The propensity score is often estimated for binary A with a logistic regression model of A on L.
Once the propensity score has been estimated, it is used to construct individual weights that are
used to target a specific population, such as those given below for the ATE and ATT, respectively.
Ŵi “
IpAi “ 1q
P̂ pA “ 1|Liq
`
IpAi “ 0q
P̂ pA “ 0|Liq
Ŵ Ti “ IpAi “ 1q ` IpAi “ 0q
P̂ pA “ 1|Liq
P̂ pA “ 0|Liq
The Ŵi weights were proposed by Robins et al. (2000) for estimating the ATE, and the Ŵ Ti
were first proposed by Sato and Matsuyama (2003) and are used to target the ATT. Both target
estimands can be expressed as parameters of marginal structural models (MSMs) (Robins et al.,
2000; Hernán and Robins, 2020). The MSMs used for estimating the ATE or ATT, respectively,
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can be written
ErY as “ α0 ` α1a
ErY a|A “ 1s “ γ0 ` γ1a
and therefore α1 represents the ATE and γ1 the ATT. Due to the fundamental problem of causal
inference, the parameters in the above models are not identifiable in practice. However, using
the previously mentioned standard causal assumptions, the parameters in the model above can be
consistently estimated by fitting the simple linear regression model
ErY |As “ θ0 ` θ1A
using weighted least squares with weights Ŵi (for ATE) or Ŵ Ti (for ATT), where Y represents
the outcome of interest and can either be discrete or continuous (Joffe et al., 2004). The desired
treatment or exposure effect θ1 can be estimated by what is sometimes referred to as the differ-
ence in Hajek or modified Horvitz-Thompson estimators, which can have performance advan-
tages over the Horvitz-Thompson estimator (Horvitz and Thompson, 1952; Särndal et al., 1992;












for a sample of size n (Lunceford and Davidian, 2004). Note that swapping Ŵ Ti in for Ŵi would
yield the estimated ATT. Thus, simple linear regression can be applied to the “pseudo-population”
mentioned previously to obtain consistent estimates of the treatment or exposure effect.
While IPW carries the advantage of not needing to specify a model for the outcome Y , the
model for A|L must be correctly specified to ultimately obtain consistent exposure effect esti-
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mates. Additionally, near violations of any necessary assumptions can result in extreme values of
the propensity score, which can lead to highly variable estimates (Cole and Hernán, 2008).
1.4.2.1 Two-Phase Outcome-Dependent Sampling Data
IPW as outlined above assumes an independent and identically distributed (i.i.d.) sample
with equal probability of selection for all individuals. However, there are many instances when
deviations from this sample type are required to accomplish the study objectives. For instance,
with the CBCS one of the primary goals of the study was to examine age and racial disparities
in breast cancer, so the study was designed to up-sample younger and African American women.
Probability of selection for participants in CBCS was also dependent on the outcome of interest,
first incidence of breast cancer. The CBCS study design bears close resemblance to a class called
two-phase outcome-dependent sampling designs. Specifically, the two sampling phases of this
design class are defined as follows. First, a simple random sample (SRS) of individuals is drawn
from a population; outcome data and other covariates are collected on these individuals, and used
to stratify them. Then a SRS is drawn from each stratum of the first phase sample, with known
stratum-specific selection probabilities; more data is collected on the individuals selected for this
second phase (Neyman, 1938).
In order to account for this type of study design, analyses designed originally for a single
SRS must be augmented. Wang et al. (2009) have shown how IPW can been used to estimate
exposure effects for these study designs. Additionally, Rose and Van Der Laan (2011) have de-
veloped a targeted maximum likelihood estimator that they use to estimate exposure effects with
two-stage designs. One key feature that unifies these methods is that the sampling probabilities
are assumed known.
1.4.2.2 Multinomial Outcome Data
Outcome-dependent sampling is commonly done with respect to a binary outcome, e.g.,
first incidence of breast cancer. However, many disease outcomes are dichotomized for ease of
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analysis but are not truly binary. Staying with the breast cancer example, there are now multiple
known subtypes of breast cancer and researchers may be interested in estimating exposure effects
for these different subtypes. IPW has been used for estimation of exposure effects on multinomial
outcomes (Richardson et al., 2018), but not in the context of outcome-dependent sampling. In the
context of competing risks, Moodie et al. (2014) has developed an IPW approach to estimate the
parameters of a marginal structural Cox model using time-to-event data.
1.4.3 Parametric G-formula
The parametric g-formula, also referred to as standardization, entails fitting an outcome
regression model and then averaging the predicted outcomes across all individuals for a fixed
level of the exposure. This method is somewhat utilized in the literature, but its use is not as
widespread as that of IPW. It was originally presented by Robins (1986), and can also be used to
estimate treatment effects such as the ATE and ATT when the usual causal assumptions can be








EpY |A “ a, Liq





EpY |A “ a, Liq
where the sample is size n, and n1 is the number of treated individuals in the sample. Snowden
et al. (2010) demonstrate a clear algorithm for computing the ATE using the g-formula that they
refer to as g-computation. Wang et al. (2017) extend the algorithm presented in Snowden et al.
(2010) to compute the ATT. As suggested by the equations shown above, both rely on first fitting
an outcome regression model such as






by ordinary least squares (OLS) where β2, β3 are parameter vectors of length J . With the pa-
rameter estimates from this model, fit using data from all n subjects, and the g-computation
algorithm, the following consistent estimates result
ATÊ “ β̂1 ` β̂
T
3 L̄




where L̄ and L̄˚ are vectors of length J with elements equal to the sample means of the J con-
founding variables in the whole sample and in the treated, respectively.
An advantage of the g-formula is that it requires no specification of a propensity score model.
However, an outcome model for Y |A,L must be correctly specified or this method could produce
biased effect estimates. Statistical validity of the IPW and parametric g-formula methods rely on
asymptotic justifications, and are not guaranteed to perform well for small sample sizes.
1.4.4 Variance Estimation
When estimating the variance of exposure effect estimators, researchers must decide between
a variety of methods, most commonly either an estimating equations approach (Stefanski and
Boos, 2002) or a resampling approach. With an estimating equations approach, the researcher
chooses whether or not they will take into account estimation of the propensity score (for IPW)
or the population means of the confounders (for parametric g-formula). The estimating equations
approach is closed-form, but can require code beyond standard software if accounting for propen-
sity score or confounder mean estimation. Bootstrapping is a common resampling method used
for variance estimation (Efron and Tibshirani, 1986), and takes estimation of the propensity score
or confounder means into account. However, resampling methods are not closed-form and can
be computationally intensive. In practice, the approach taken varies by effect estimation method
(IPW, parametric g-formula), and by target estimand (ATE, ATT).
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1.4.4.1 When Target Estimand is the ATE
Lunceford and Davidian (2004) published what is now a well-known result, stating that the
variance for the ATE when using IPW can be conservatively estimated by treating the propen-
sity score as known. This conservative variance estimator is referred to as the Huber-White or
robust sandwich variance estimator (Huber, 1967; White, 1980), and is used for many other pur-
poses such as variance estimation in models fit with generalized estimating equations (GEE) or in
survey sampling to account for sampling design in variance estimation (Liang and Zeger, 1986;
Lumley and Scott, 2017). This result is convenient because the variance can be estimated read-
ily with standard software when not accounting for estimation of the propensity score, whereas
accounting for this estimation is more computationally involved. Due to its computational conve-
nience, the Huber-White sandwich variance estimator is often utilized in this context.
When using the parametric g-formula, bootstrapping is a common method used for estimat-
ing the variance (Snowden et al., 2010; Wang et al., 2017). Another possibility is to estimate the
variance using the estimating equations approach, accounting for estimation of the means of the
confounding variables.
1.4.4.2 When Target Estimand is the ATT
When computing the ATT using IPW, the literature shows the application of a variety of
methods to estimate the variance. Imbens (2004) recommended using a bootstrap procedure
for variance estimation, and there are various recent examples of researchers taking this ap-
proach (Abdia et al., 2017; Jawid and Khadjavi, 2019; Were et al., 2017). Pirracchio et al. (2016)
use their own “rough but simple” estimator for the variance of the ATT, Ramsey et al. (2019) use
a sandwich-type variance estimator from the survey R package (Lumley and Scott, 2017), and
Brookhart et al. (2013) also use a robust variance estimator similar to that used in GEE; each of
these approaches treat the weights as known.
In their paper investigating finite sample properties of point and interval estimators for the
ATT, Bodory et al. (2018) use a generalized method of moments (GMM)-based estimator for
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the variance of the IPW ATT estimator, which does account for estimation of the propensity
score. The IPW estimator in their paper is of the same form as the difference of Hajek estimators,
with the exception of the link function used to estimate the propensity score. On the issue of
accounting for propensity score estimation, Bodory et al. (2018) remark that, “there is some
common sense among practitioners that ignoring estimation error of the propensity score is likely
to lead to conservative inference... However, it must be pointed out that there is no guarantee of
this to be valid for the ATET in general.” This acknowledgement reflects that there is no existing
proof of the properties of the ATT variance when treating the propensity score as known.
As with the ATE, bootstrapping is a common method for estimating the variance when using
the parametric g-formula. The estimating equations approach may also be used here as well,
again accounting for estimation of the means (in the treated) of the confounding variables.
1.4.4.3 Options in Software
In SAS software, the CAUSALTRT procedure can estimate the ATE and ATT using IPW or
the parametric g-formula (called ‘regression adjustment’ in documentation), and can provide
consistent variance estimates using the estimating equations approach or bootstrapping (SAS In-
stitute Inc., 2018). Stata can perform IPW using the teffects ipw command, and can estimate both
the ATE and ATT; choices for variance estimation method with this command include both an
estimating equations approach (option ‘robust SVE’) or a bootstrapping approach (option ‘boot-
strap’), both of which account for estimation of the propensity score (StataCorp, 2019). For R
users, there are a variety of options for implementing both IPW and the parametric g-formula and
getting variance estimates for the ATE and ATT. One option for IPW in R is using the ipw pack-
age for weight estimation (van der Wal and Geskus, 2011), the glm function for getting the effect
estimates, and the geex package for consistent variance estimation (Saul and Hudgens, 2020).
If using the parametric g-formula method instead in R, one may use the workflow provided in
Snowden et al. (2010) (R Core Team, 2020).
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1.5 Summary
The central theme of this manuscript is valid inference on exposure effects from observa-
tional genomics data. These exposure effects are important in a variety of contexts, and can ulti-
mately guide future research and inform health policies. Causal inference methods such as IPW
and the parametric g-formula may be viable alternatives to regression-based methods when it
comes to adjusting for confounding and certain biases introduced by the study design. Addition-
ally, careful attention must be paid to variance estimation, regardless of the method chosen.
Chapter 2 closely examines the performance of IPW and the parametric g-formula for esti-
mating the effect of smoking on gene expression in simulation studies and in the METSIM data.
The performance of these causal methods are then compared to that of the common regression
approach. This chapter also touches on best practices for variance estimation for the exposure
effect estimators. However, an in-depth exploration of variance estimators for the IPW ATT esti-
mator is given in Chapter 3. Here the IPW ATT variance estimators with and without accounting
for propensity score estimation are compared using asymptotic calculations, simulation studies,
and an analysis of the METSIM study data. Finally, Chapter 4 addresses how to conduct valid
inference on exposure effects from two-phase outcome-dependent sampling data. Specifically, an
extension is proposed to an existing IPW estimator for these study designs that will allow for con-
sistent estimation of exposure effects on a multinomial outcome. This extended IPW estimator is
compared to common regression approaches in simulation studies and in an analysis of the CBCS
data.
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CHAPTER 2: ASSESSING EXPOSURE EFFECTS ON GENE EXPRESSION
2.1 Introduction
Increasing numbers of large-scale observational genomic datasets are available, in which
tissue is collected from human donors sampled from a population. These donors differ in various
ways, for example they may differ by age, sex, and other demographic variables, as well as by
clinical or exposure variables such as body-mass index (BMI), diet, level of physical activity,
history of medicine use, history of smoking or alcohol use, or various environmental exposures.
Investigators are often interested in assessing the effect of various exposures on genomic vari-
ables, such as gene expression, as this may be useful to generate hypotheses about potential cel-
lular mechanisms through which exposures may influence the development of diseases in human
populations. Gene expression is a common molecular measurement in the context of exposure
effects, although additional genomic assays, such as methylation, metabolites, protein abundance,
may also be of interest.
A number of statistical methods have been proposed to address the problem of structural
technical variation in gene expression measurements (Gagnon-Bartsch and Speed, 2012; Leek
and Storey, 2007; Stegle et al., 2012), where structural refers to variation in the measurements
across samples that is common across many genes. These methods address sample non-independence
with a focus on estimation of latent factors, orthogonal to the biological condition of the samples,
to be included in a linear model framework as regressors to account for the technical variation in
the measurements. These methods can account for differences in measurements among sample
preparation batches that may otherwise impair correct inference of differences across the biolog-
ical conditions. Additionally, methods have been proposed to address sample correlations that
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arise from biological sources, for example repeated measures or genetically related individuals.
Such sample non-independence can be addressed by explicit modeling of the known sample cor-
relation structure as in a random effects framework (Cui et al., 2016); software for this approach
include the duplicateCorrelation method (Smyth et al., 2005) in the limma R/Bioconductor pack-
age (Smyth, 2004), the ShrinkBayes R package (Van De Wiel et al., 2012), or the MACAU R
package (Sun et al., 2017), all of which can be run from within the R environment (R Core Team,
2020).
Regression frameworks alone may not be able to properly address the problem of confound-
ing variables, whether measured or unmeasured, in observational datasets. Confounding is an
issue when estimating causal effects, and as such is a distinct problem from the technical and
biological sources of correlations among samples described above. Confounding has received
relatively less attention in computational genomics, compared to the problems of structural tech-
nical variance or repeated measures. Existing work addressing confounding in observational
genomic datasets has focused on sample matching (Heller et al., 2008), the combination of tar-
geted minimum loss-based estimation (TMLE) and empirical Bayes shrinkage estimation (Hejazi
et al., 2017), and TMLE for differential methylation controlling for observed methylation at
neighboring genomic sites (Hejazi et al., 2018).
Since the exposure in an observational study is not randomly assigned, there is often con-
founding of the effect of exposure on the outcome. In general, randomized clinical trials to assess
how various exposures affect gene expression cannot be conducted in human populations for ethi-
cal or feasibility reasons. Similar randomized studies can be performed on model organisms, but
there is unique value in understanding the mechanism of these exposures in humans, and human
populations are readily available for observational studies. In light of the increasing number of
observational genomics studies on humans and the anticipated presence of confounding in such
studies, methods of exposure effect estimation are worth further investigation.
For many studies, it is often useful to assess exposure effects on gene expression in the ex-
posed individuals. This may be the case when researchers have particular interest in the effect
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of an exposure only on those types of individuals who likely will experience the exposure. For
example, when studying the effect of smoking, it is often most relevant to obtain effect estimates
interpretable for those who actually smoke, as opposed to the effect smoking would have, averag-
ing over all the persons in the general population. In these cases, the target estimand is referenced
as the exposure effect in the exposed; this terminology will be used interchangeably with the av-
erage treatment effect in the treated (ATT) throughout. In contrast, the average treatment effect
(ATE) is a different estimand and is interpretable in the context of the population as a whole, in-
cluding both treated and untreated individuals. This paper will focus on obtaining estimates for
the former, the ATT.
The conventional approach to quantifying the effect of exposure, while attempting to adjust
for confounding, is to fit a linear model of gene expression with the exposure and various poten-
tial confounders as covariates. In this approach, the estimated coefficient of the exposure variable
is often interpreted as an estimate of the exposure effect. However, fitting the conventional linear
model falls short of our goal in two respects: (1) it does not directly produce an estimate of the
effect of interest, the effect of the exposure in the exposed individuals, who may differ in various
respects from unexposed individuals, and (2) it may not appropriately adjust for confounding,
resulting in estimates that are not consistent and confidence intervals that do not provide their
nominal coverage. For these reasons, this paper demonstrates existing causal inference methods
that can be employed in these scenarios to adequately adjust for confounding and return consis-
tent exposure effect estimates and valid confidence intervals.
Regression, inverse probability weighting (IPW), and the parametric g-formula are compared
herein for obtaining exposure effect estimates. Both IPW and the parametric g-formula are meth-
ods established and widely applied to observational studies in the causal inference and epidemi-
ology literature. This paper seeks to demonstrate that these methods also have utility in the space
of observational genomics. In general, IPW uses weights to construct a “pseudo-population” in
which there is no longer confounding of the effect of an exposure on the outcome of interest; sim-
ple linear regression is then applied to this “pseudo-population” to obtain consistent estimates of
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the exposure effect (Robins et al., 2000). The parametric g-formula, also referred to as standard-
ization, entails fitting an outcome regression model and then averaging the predicted outcomes
across all individuals for a fixed level of the exposure. Both IPW and the parametric g-formula
rely on standard assumptions of causal inference (conditional exchangeability, positivity, and
consistency), but they differ in the modeling assumptions required (Naimi et al., 2017). Statistical
validity of the IPW and parametric g-formula methods rely on asymptotic justifications, and are
not guaranteed to perform well for small sample sizes.
The following is an outline for the remaining sections of this paper. A brief summary is given
of the models used, followed by more extensive description in the Methods section for both the
simulation study and data analysis; formal definitions are left to the Supplementary Methods. In
the Results section, the methods are compared in simulations and a data analysis. Simulation
studies are based on the Metabolic Syndrome in Men Finnish cohort (METSIM) (Laakso et al.,
2017) analysis dataset (n = 770). In particular, scenarios falling into three categories for a binary
exposure effect on gene expression are investigated: no confounding, and confounding both with
and without interaction(s) between exposure and covariates. The METSIM cohort data is then
analyzed to investigate the effect of current smoking on gene expression in adipose tissue. The
Discussion section concludes with reviewing and providing insight into the main results, and
addresses limitations of and future directions for this research. Appendix A.1 demonstrates the
equivalence of the g-formula estimator presented in the main text and the g-computation algo-
rithm of Snowden et al. (2010). The Supplementary Methods (Appendix A.2) gives details on
the models for the regression, IPW, and g-formula approaches, as well as estimates of standard
errors and assumptions required for each approach. In the Supplementary Results (Appendix
A.3), it is first established why the proposed methods are being compared to linear regression
alone, and not to the linear model with empirical Bayes moderation of the standard errors (for
example, as implemented in the limma package (Smyth, 2004)). This section also contains ad-
ditional regression analysis results for both the simulated data sets and the METSIM cohort data.
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The Supplementary Results section concludes with reporting of the RMSE for each estimation
approach using the simulated data, and sensitivity analyses for the METSIM cohort data.
2.2 Methods
2.2.1 Summary of models compared
Three exposure effect estimation approaches were assessed in the following evaluation: tra-
ditional linear regression, inverse probability weighting, and the parametric g-formula. In fitting
the models associated with each approach, it was assumed that the models were correctly speci-
fied, the set of confounders identified was sufficient to adjust for confounding, and the data were
free from selection bias and systematic measurement error. The regression model with the ex-
posure and potential confounders as predictors was fit using ordinary least squares for both the
parameter estimates and their standard errors, in keeping with the conventional approach. For
the IPW approach, the confounders were used as predictors in a logistic regression model of the
exposure to obtain the weights, and the weights were used in the simple linear regression model
of gene expression on the exposure using weighted least squares. In the g-formula approach, all
potential confounders were centered at the mean value in the exposed, and the linear regression
model with the exposure, centered confounders, and their interactions was fit using ordinary least
squares. The standard errors for both the IPW and g-formula estimators were computed using
stacked estimating equations (Stefanski and Boos, 2002). The details of using these methods with
observational genomics data are described further in the Methods Section, formally defined in the
Supplementary Methods section that follows the main body of the paper.
2.2.2 Simulation Study
Performance of methods was first compared using a simulation. The simulated covariates
and exposure were based on counterparts from the METSIM data analysis in the next section.
Specifically, the simulated variables included a current smoking indicator and five variables
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considered to be potential confounders of the relationship between current smoking and gene
expression. Table 2.1 below gives more details regarding variable distributions and dependencies.
Table 2.1: Definitions of exposure and confounding variables for simulation study comparing
regression, IPW, and the parametric g-formula
Variable Distribution Dependencies
Age (age) Normal None
Alcohol Consumption (alc) Exponential None
Vegetable Consumption (veg) Binary None
Hobby Exercise (hex) Categorical (4 levels) veg
BMI (bmi) Normal veg, hex
Current Smoking (smk) Binary alc, bmi, veg, hex
Following the generation of the variables in Table 2.1, normalized gene expression values
for various scenarios were simulated as well. For scenarios where no confounding was present,
the mean of the expression values were dependent on only the exposure or none of the variables.
When confounding was present, the mean expression values were dependent on both the expo-
sure and the other covariates, with some scenarios including interactions between the exposure
and the covariates. Expression values were generated with different means for each individual
and each gene, according to the simulated exposure and covariates. The mean for gene g and
individual i was
µgi “ βg1 agei ` βg2 alci ` βg3 vegi ` βg4 hexi ` βg5 bmii`
smki pβg6 ` βg7 alci ` βg8 vegi ` βg9 hexi ` βg10 bmiiq
where the βgk, k “ 1, ..., 10, varied by gene and were restricted to βgk P r´2, 2s for this simu-
lation study. Here age, alc, and bmi were each centered about their population mean and scaled.
Note that there was no quadratic age term and no interaction term for age and smoking in the
true model for mean expression, although the former was included in the analysis models; these
terms can be thought of as not contributing to the true mean gene expression for any individual.
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The standard deviation of each gene was set to the same value to aid with comparing results for
different genes, and was equal to 0.24.
The variables listed in Table 2.1 were generated for a population of 10 million individuals,
from which the true ATT was calculated for each gene. From this population, 1000 sets of 770
individuals were randomly selected with replacement to build the analysis datasets. The sampling
algorithm allowed for the same individual to be present in more than one dataset, but not more
than once within a single dataset.
In all instances the regression model had the same form shown in equation A.4 of the sup-
plementary materials, namely the exposure and covariates (with both linear and quadratic age
terms) were each present as main effects in the model and no interaction terms were included; for
simulation study results of the regression analyses including interactions in the model, see Sup-
plementary Results. The covariates age, age2, alc and bmi were centered at their sample mean
and scaled for each dataset, as would typically be done to avoid collinearity with the intercept.
The standard errors used to construct the 95% confidence intervals were obtained through fitting
the model with ordinary least squares.
For the IPW approach, first the logistic regression model in equation A.5 of the supplemen-
tary materials was used to compute the components needed for the weights for each dataset, with
terms for the five covariates and a quadratic age term. Weights for the ATT were then constructed
according to expression A.6 of the supplementary materials. Then the linear regression model
of gene expression in A.7, with only the exposure and an intercept, was fit with the weights to
obtain the effect estimate. Standard error estimates used to obtain the 95% confidence intervals
were computed with the stacked estimating equations approach using the geex package (Saul and
Hudgens, 2020) in R, taking into account estimation of the weights by stacking the estimating
equations for the logistic regression model with those used in computing the IPW estimator.
The regression model given in equation A.8 of the supplementary materials was used to ob-
tain the g-formula estimate for each dataset. It contained variables for the main effects of the
exposure and covariates (including both linear and quadratic age) as well as interactions between
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smk and each of bmi, veg, hex, and alc. Since the ATT is being compared across methods in
this simulation study, the non-exposure covariates were all centered at the sample mean in the
exposed. The standard error estimates used for the 95% confidence intervals were computed with
stacked estimating equations by passing geex the set of stacked estimating equations correspond-
ing to the covariate means and the regression model parameters.
2.2.3 METSIM Smoking Exposure Effect
In the METSIM project dataset, the goal was to obtain the estimated effect of current smok-
ing on gene expression in the smokers, adjusting for the set of potential confounders: linear and
quadratic age, BMI, alcohol consumption, vegetable consumption, and hobby exercise. The data
consisted of adipose gene expression values and several covariates, measured for n “ 770 individ-
uals (details on data preprocessing in Supplementary Methods). There were no missing outcome,
exposure, or covariate values. This cohort was analyzed in Civelek et al. (2017), where BMI and
linear and quadratic age were considered confounding variables for various phenotypic traits.
This analysis, and consultations with a subject-matter expert, guided the choice of the confound-
ing variable set. Note that current smoking was not examined by Civelek et al., so their analyses
were not compared directly to those in this paper. Each of the three methods introduced above
were implemented for this cohort in the analyses that follow.
Table 2.2 briefly summarizes the variables used in this analysis; the range, mean and standard
deviation are reported for continuous variables and the levels and distribution are given for each
categorical variable. For hobby exercise, higher levels denote increased activity levels.
Note that the models used for the data analysis had the same form as those fit for the sim-
ulation study, described in the section above. The estimated exposure effect was obtained us-
ing regression, IPW, and the g-formula for each of the 18,510 genes; the coefficient for current
smoking represented the exposure effect in each model. The models were fit and standard errors
computed, again using the same process as for the simulation study; for results of the regression
analyses including interactions in the model with the METSIM data, see Supplementary Results.
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Table 2.2: Descriptive statistics for the METSIM cohort data.
Variable Range Mean (SD)
Age (yrs) (45, 68) 55 (5)
Alcohol Consumption (g{wk) (0, 1134) 105 (119)
BMI (kg{m2) (18.5, 48.1) 26.6 (3.5)
Level Proportion
Vegetable Consumption Everyday 0.83
Not Everyday 0.17




Current Smoking Yes 0.17
No 0.83
With each approach, a t-test of no effect of exposure on gene expression was performed for each
gene and the resulting p-values were adjusted using the correction from Benjamini and Hochberg
(1995) to control the false discovery rate.
To compute weights for the 770 individuals, the logistic regression model of current smoking
was fit with the previously listed covariates as predictors. Before computing effect estimates
and standard errors, it is good practice to check that the weights have a mean value close to the
expected value (details in Supplementary Methods) and that none of the weights are extreme. The
weights had mean value 0.34, which was exactly what was expected for these data. There was
one weight with a value of 5.26, substantially larger than the rest; for this reason, a sensitivity
analysis was conducted in the Supplementary Results section where the observation with this
large weight was deleted and the same analysis was performed again to investigate the influence
of this observation.
For both the g-formula and regression methods, leverage values were computed for each
observation to determine if there were any influential points in these analyses; the same observa-
tion returned the largest leverage point for both the g-formula and regression, which took values
0.38 and 0.11 respectively. In both instances these leverage values were approximately twice the
magnitude of the next largest value, so another sensitivity analysis was conducted in the Supple-
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mentary Results where the observation with this large leverage value was deleted and the analysis
was performed again to investigate its influence.
2.3 Results
2.3.1 Simulation Study
The empirical bias and confidence interval coverage and width for the regression, IPW, and g-
formula estimators are shown in Table 2.3, averaging over 1000 simulations per scenario. While
there were instances where all estimators appeared to perform well, the IPW and g-formula es-
timators provided advantages over regression in a subset of the simulated scenarios. In partic-
ular, the IPW and g-formula estimators remain unbiased and meet nominal confidence interval
coverage in all scenarios, but the regression estimator manifests bias and fails to meet nominal
coverage in the presence of exposure-covariate interactions. The reported coverage represents the
proportion of confidence intervals which included the true value of the ATT. The true ATT value
is shown for each scenario, and is based on the original population of 10 million individuals. The
null case where there was no effect of current smoking on gene expression is shown in addition to
several representative scenarios where confounding was present, two without and three with one
or more interactions between exposure and confounders.
Table 2.3: Average empirical bias and 95% confidence interval (CI) coverage and width for the
regression (Reg), IPW, and g-formula (Gf) estimators.
True Estimate Bias 95% CI Coverage 95% CI Width
Scenario ATT Reg IPW Gf Reg IPW Gf Reg IPW Gf
Null Case 0.00 0.00 0.00 0.00 0.96 0.96 0.95 0.10 0.10 0.10
No Interactions 1 -2.00 -0.00 0.00 0.00 0.95 0.96 0.95 0.10 0.11 0.10
No Interactions 2 2.00 0.02 0.01 -0.00 0.91 0.92 0.94 0.15 0.35 0.18
Interactions 1 1.59 0.12 0.00 0.00 0.34 0.96 0.96 0.18 0.39 0.39
Interactions 2 -0.36 -0.20 0.00 0.00 0.19 0.96 0.95 0.23 0.51 0.51
Interactions 3 -1.75 -0.20 0.01 0.01 0.37 0.95 0.95 0.31 0.70 0.70
True ATT values in these simulations are in units of log2 fold change in gene expression.
As normalized gene expression data are often on the log2 scale, linear effects are commonly
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interpreted as log2 fold changes with respect to the raw gene expression scale (Smyth, 2004). The
most extreme scenario shown here, where the true ATT is 2.00, thus represents a 4-fold change
in gene expression attributable to smoking. Additional simulation studies were conducted that
are not shown in this table, but the results were similar to those included. Across all simulations
run, the average bias of the regression estimator took values in the range r´0.29, 0.29s, whereas
the IPW and g-formula average biases were contained to r´0.01, 0.01s. For this simulation study
setup, the regression bias appears to be larger in magnitude when interaction terms involving
alcohol and hobby exercise contributed to the true ATT.
When smoking and the confounders did not interact to influence gene expression, e.g., the
first three examples in Table 2.3, all methods met nominal coverage and yielded no bias on aver-
age. In scenarios where interactions existed between smoking and the confounders, the regression
effect estimator had nonzero average bias and substantially below nominal confidence interval
coverage. The IPW and g-formula estimators both resulted in very low or no bias on average,
and both uniformly met (or very nearly met) the nominal confidence interval coverage. Except
in the null case, the IPW and g-formula estimators were generally more variable than the regres-
sion estimator. When smoking and the confounders interacted, the IPW and g-formula estimates
had confidence intervals that were on average approximately twice as wide as those for regres-
sion. Of the two methods that overall maintained the nominal coverage across scenarios, IPW
and g-formula, they tended to have comparable interval width except in one of the no-interaction
scenarios, in which IPW had nearly double the average interval width of g-formula.
2.3.2 METSIM Smoking Exposure Effect
Regression, IPW, and g-formula were applied in order to assess the effect of smoking on
gene expression among smokers in the METSIM cohort. Estimates and confidence intervals for
each of the three methods, for the top two genes as ranked by p-value are presented in Figure
2.1a - 2.1b (the top two genes are shown as their effect sizes and test statistics were apprecia-
bly larger compared to the other genes). The three methods were in agreement on the ranking
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for the top three genes, but beyond this the rankings were not consistent across method (Fig-
ure 2.1c). The top two genes in terms of estimated effect size and test statistic were CYP1A1
and CYP1B1, which were expected as they play a role in metabolizing cigarette smoke (Nebert
and Russell, 2002). The confidence intervals for the IPW and g-formula estimates of the top
two genes were similar in width, and the regression confidence interval was substantially less
wide. While the ´ log10 adjusted p-values for the top two genes were all large for each of the
three methods (highly significant), those from regression were much larger than those from IPW
and the g-formula (CYP1A1: R=119, W=44, G=44; CYP1B1: R=30, W=18, G=20). This is in
accordance with the displayed difference in confidence interval widths for the smoking effect esti-
mates of these two genes. Although the ATT estimates were similar across methods for the genes
shown, instances of substantial differences in standard error produced vastly different confidence
intervals and p-values.
IPW and the g-formula tended to produce larger p-values than regression for these data,
though this was not the case for every gene (Figure 2.1c). Note that in this figure the top two
genes were not represented, as their ´ log10 adjusted p-values were much larger than the others.
Additionally, the smoking effect estimates for all genes except the top two were in the range
p´0.5, 0.5q, with many very close to zero.
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(a) Top Ranked Gene: CYP1A1 (b) Second Ranked Gene: CYP1B1
(c) Remainder of Top 50 Genes
Figure 2.1: METSIM analysis results for the top 50 genes, ranked by p-value. (a)-(b) Estimates
and 95% confidence intervals for the effect of current smoking in the smokers for genes CYP1A1
and CYP1B1, respectively. Note that the null value for the smoking effect estimate
(log2 fold change “ 0) is not included on the x-axis. (c) ´ log10 adjusted p-values for the top 50




Geneticists and epidemiologists may analyze differential gene expression due to exposures in
a population in order to generate hypotheses as to how those exposures may be related to health
outcomes. Results of these analyses, i.e., lists of genes affected by the exposure under a false dis-
covery rate bound and their associated effect sizes, may be inaccurate and irreproducible across
study populations unless potential confounders of the exposure and gene expression are properly
adjusted for. Here, exposure effect estimates were compared using causal inference techniques
such as IPW and the parametric g-formula, as well as with common practice techniques such
as regression. Comparisons were performed across simulated data and a data analysis in which
gene expression was measured in subcutaneous adipose tissue. Tissue donors also had various
clinical and demographic covariates measured, and it was desired to adjust for differences among
the exposed and unexposed donors when estimating the ATT. Analyses of the METSIM cohort
found that estimation method did not make a substantial difference for the effect estimates for
the top two genes, CYP1A1 and CYP1B1. Simulations based on the METSIM data showed that
there was potential for the regression estimate to be biased, but the effect biases observed in the
data analyses were small. Differences between the methods were most pronounced when exam-
ining the standard errors and therefore also the resulting confidence intervals and p-values. In
particular, simulations based on the METSIM data showed that if there were any interactions of
the exposure with the confounder(s), the regression method produced confidence intervals that
can have far below nominal coverage. Furthermore, what may appear to be modest changes in
standard errors can produce a dramatically different set of adjusted p-values for a given set of
genes.
In addition to the standard errors, regression as applied here differs from IPW and the para-
metric g-formula in that the regression estimates do not represent the effect of exposure in the
exposed, but rather in the population as a whole. While IPW and the g-formula can be adapted to
produce the exposure effect in the population or sub-population of interest, regression estimates
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remain population-wide estimates — unless operating under the assumption that ATE and ATT
are equal.
It should be mentioned that if all appropriate interaction terms were included in the regres-
sion model, the parameter estimates could be combined to yield consistent conditional exposure
effect estimates. However, this approach was not taken here for two reasons: (i) the goal was
to obtain one exposure effect estimate that could be read directly from software output without
additional steps, and (ii) the exposure effect estimate constructed via combination of exposure
and interaction terms would be interpreted conditional on values of the covariates, whereas the
desired exposure effect estimate has a marginal interpretation. Expanding on this second reason,
regression with all appropriate interaction terms would result in a variety of exposure effects
across combinations of covariates used for conditioning, as opposed to the causal approaches
presented here which provide one exposure effect integrating over the exposed individuals. If
all appropriate interaction terms were included in the regression model and centered at the mean
in the population of interest, then the regression model would be equivalent to the parametric
g-formula model.
Often in analyses of exposure effects on microarray gene expression, the limma method
is used to fit the regression models and obtain a moderated t-statistic (Smyth, 2004), whereas
here the ordinary t-statistic was used. The simulation results illustrating the rationale behind this
choice are included in the Supplementary Results section. In short, the sample size of the cohort
analyzed here (n “ 770) was sufficiently large that the ordinary and moderated t-statistics are
practically equivalent. More recently, another method has been proposed involving the combi-
nation of TMLE and empirical Bayes shrinkage estimation, which has demonstrated utility with
small and moderate sample sizes (Hejazi et al., 2017). The intended audience of this paper is
working with larger datasets, allowing for reliance on large sample theory; for this reason the
simpler and more readily available approach was used for the regression analysis. Here, pre-
normalized microarray gene expression, which takes continuous values, was analyzed, while
RNA sequencing experiments result in count-valued observations for gene expression. In order
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for the causal inference approaches shown here to be applied to count data from RNA sequencing,
it would be desirable to first perform library size scaling and apply a variance stabilizing transfor-
mation to the gene expression (Anders and Huber, 2010; Law et al., 2014), though such datasets
and procedures were not evaluated in the present work.
The IPW and parametric g-formula approaches are both presented here as alternates to re-
gression that adequately adjust for confounding in a wider variety of circumstances. While IPW
and the g-formula both accomplish this goal, they require slightly different assumptions and
they have different strengths and weaknesses. The IPW estimator relies on correct specification
of the exposure model, which is often more plausible than correct specification of the outcome
model. IPW can be sensitive to extreme weights, as shown in the sensitivity analysis results for
the METSIM data, and can be more variable than the g-formula estimator. While the consistency
of the g-formula estimator relies heavily on the correct specification of the outcome model, it
appears to be less sensitive to extreme values of the covariates and can be less variable than the
IPW estimator. Due to the limited overall differences in the bias and efficiency of the IPW and g-
formula estimators, the researcher is encouraged to choose among methods based on their relative
confidence in specification of the exposure or outcome models.
There are several assumptions made in these analyses which may be violated and deserve
further exploration. Firstly, the assumption of causal consistency states that there are not multiple
ways to be a current smoker. This assumption is clearly not met since the amount of cigarettes
smoked daily can vary from person to person, but this assumption can be replaced by another
less stringent assumption. In particular, it can more reasonably be assumed that these different
versions of exposure do not have any bearing on the causal effect; this is referred to as treatment
variation irrelevance (Vander Weele, 2009). The data analyses above rely on the additional as-
sumptions that the set of confounders L are sufficient to adjust for confounding. In addition to
confounding, there may be other possible sources of bias when estimating exposure effects. For
example, the methods here implicitly assume no systematic measurement error; for methods that
account for measurement error see Hernán and Cole (2009); Kuroki and Pearl (2014); Suzuki
31
et al. (2016); Hernán and Robins (2020). In addition, the methods described here assume the data
constitute a random sample from the target population. Non-random sampling from the popula-
tion of interest may also introduce bias; for methods to accommodate biased sampling, see Stuart
et al. (2011); Lesko et al. (2017); Buchanan et al. (2018). If any of these assumptions are unmet
then the exposure effect estimates may be biased. Furthermore, formal arguments for the methods
presented rely on large sample theory; while there is some empirical evidence suggesting that,
for example, IPW can perform well with moderate sample sizes (Pirracchio et al., 2012), these
methods are not guaranteed to perform well for small or moderate samples.
The performance of doubly robust estimators for estimating exposure effects on gene ex-
pression could be investigated in future work. Doubly robust estimators have been shown to
provide advantages over IPW or the g-formula (Lunceford and Davidian, 2004; Moodie et al.,
2018; Naimi and Kennedy, 2017), and could conceivably allow a relaxation of certain model-
ing assumptions in observational genomics analyses while maintaining the desirable properties
of causal methods. Additionally, this paper focuses on binary exposures but future work could
expand this to allow for continuous or longitudinal exposures.
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CHAPTER 3: ON VARIANCE OF THE TREATMENT EFFECT IN THE TREATED
USING INVERSE PROBABILITY WEIGHTING
3.1 Introduction
Observational studies are often used to draw inference about the effect of a treatment (or ex-
posure) on an outcome of interest, especially in settings where randomized trials are not feasible.
Common estimands for these types of analyses are the average treatment effect (ATE) and the
average treatment effect in the treated (ATT). These estimands answer different causal questions,
so it is critical to first establish the motivation and goals of inference when choosing a target
estimand. Smoking, for example, is a commonly studied exposure where investigators may be
interested in the ATT (Moodie et al., 2018). With current smoking as the exposure, the ATT con-
siders the effect of smoking only among those who currently smoke. On the other hand, the ATE
contemplates the counterfactual scenario where everyone in the population smokes versus when
no one smokes, which may not be of interest from a public health perspective. Another common
example comes from pharmacoepidemiology, where the effect of a certain drug in users of that
drug can often be the most relevant estimand for public health research (Brookhart et al., 2013;
Taylor et al., 2013; Nduka et al., 2016). The ATT has utility across a range of disciplines where
there is interest in treatment effects among only those individuals who ultimately receive the treat-
ment. Other contexts in which the ATT can be the preferred target of inference include health
behavior and policy (Rawat et al., 2010; Austin, 2011; Boulay et al., 2014; Were et al., 2017),
ecology and environmental management (Gross and Rosenheim, 2011; Tamini, 2011; Ramsey
et al., 2019), criminology (Apel and Sweeten, 2010; Morris, 2016; Widdowson et al., 2016), and
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economics and public policy (Heckman and Vytlacil, 2001; Addai et al., 2014; Marcus, 2014;
Abdia et al., 2017; Jawid and Khadjavi, 2019).
Inverse probability weighting (IPW) is often used for estimation of treatment effects from
observational data, where confounding is expected in general. IPW estimators of the ATE and
ATT can be computed by regressing the outcome on the exposure using weighted least squares,
where the weights are functions of estimated propensity scores. The variance of the IPW ATE
estimator is often estimated by assuming the weights are known and then using the so-called
“robust” (Huber-White) sandwich estimator, which results in conservative standard error (SE)
estimation (Lunceford and Davidian, 2004; van der Wal and Geskus, 2011; Hernán and Robins,
2020). Likewise, the variance of the ATT IPW estimator is sometimes estimated by assuming the
weights are known (Brookhart et al., 2013; Pirracchio et al., 2016; Ramsey et al., 2019). How-
ever, unlike the IPW ATE estimator, there is no theoretical justification for assuming the weights
are known when estimating the variance of the IPW ATT estimator (Bodory et al., 2018). Indeed,
herein we prove that such an approach can produce either conservative or anti-conservative SE es-
timates for the IPW ATT estimator. Consequently, hypothesis tests and confidence intervals using
this approach will not be valid in general. Instead, stacked estimating equations which account
for the weight estimation can be used to compute a consistent, closed-form variance estimator for
the IPW ATT estimator.
The remaining sections of this paper are organized as follows. Section 3.2 describes the IPW
estimator for the ATT, and the corresponding variance estimators that will be compared in sub-
sequent sections. In Section 3.2.3 four simple examples are provided showing that the robust
variance estimator with the weights assumed known can be conservative or anti-conservative.
In Section 3.3 simulation studies are conducted for the four example scenarios outlined previ-
ously, and the finite sample properties of the variance estimators are explored. In Section 3.4 the
Metabolic Syndrome in Men (METSIM) cohort data are analyzed with the methods outlined in
Section 3.2. Section 3.5 concludes with a discussion of the implications of these findings. Deriva-
tions are provided in the Appendices.
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3.2 Methods
3.2.1 IPW ATT Estimator
Consider an observational study where the goal is to draw inference about the effect of a
binary exposure A on an outcome Y . For a “ 0, 1, let Y a denote the potential outcome had,
possibly counter to fact, the exposure level been a. Let Y denote the observed outcome, such that
Y “ AY 1 ` p1´ AqY 0. The ATT, the estimand of interest, is defined as ATT “ µ1 ´ µ0 where
µa “ EpY
a|A “ 1q for a “ 0, 1 denotes the mean potential outcome under treatment a among
the treated individuals.
With observational data, there is potential for confounding because individuals are not ran-
domized to exposure A. IPW can be used to adjust for this confounding of the relationship be-
tween the exposure and outcome. The inverse probability weights are functions of the propensity
scores, which are often estimated by fitting the logistic regression model
logittP pA “ 1|Lqu “ α0 ` αT1 L (3.1)
where L represents a (column) vector of J measured pre-exposure variables and α1 is a parameter
vector of length J . Assume we observe n independent and identically distributed (i.i.d.) copies
of pL,A, Y q denoted by pLi, Ai, Yiq for i “ 1, ..., n. Let α “ pα0, αT1 q and let α̂ be the maxi-
mum likelihood estimator (MLE) of α obtained by fitting model (3.1). Let hpL;αq “ P pA “
1|Lq{P pA “ 0|Lq “ exppα0`α
T
1 Lq and hpL; α̂q “ exppα̂0` α̂
T













where Ŵi “ W pAi, Li; α̂q “ Ai ` p1 ´ AiqhpLi; α̂q is the estimated weight for subject i (Sato




i“1. The two ratios in (3.2) are sometimes referred to as
Hajek or modified Horwitz-Thompson estimators (Hernán and Robins, 2020). The IPW ATT
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estimator (3.2) is consistent for ATT under the following assumptions: stable unit treatment
value assumption (Rubin, 1980); positivity, i.e., P pA “ a|L “ lq ą 0 for a “ 0, 1 and all l where
dFLplq ą 0 and FL is the CDF of L; conditional exchangeability, i.e., Y a K A|L for a “ 0, 1;
and correct specification of the model for A|L. Note that no outcome model for Y given A or L
is assumed.
A convenient way to compute (3.2) using standard software entails fitting a simple linear
regression model of Y on A by weighted least squares. The variance estimator that results from
assuming the weights are known is sometimes referred to as the robust or Huber-White (HW)
sandwich variance estimator, which is easily computed in standard software (e.g., sandwich
in R, or the REG procedure with the WHITE option in the MODEL statement in SAS). While
computationally convenient, this estimator will not generally result in valid inference, as shown
below.
3.2.2 Variance Estimators of the ATT Estimator
The asymptotic distribution of the IPW ATT estimator (3.2) can be derived using standard
estimating equation theory. In particular, let








ψ1pYi, Ai, Li, α, µq


















W pAi, Li;αqAipYi ´ µ1q








where µ “ pµ1, µ0q, ψα denotes the J ` 1 vector of score functions from the log likelihood
corresponding to model (3.1), and epLi;αq “ P pAi “ 1|Liq “ hpLi;αq{t1 ` hpLi;αqu is the
propensity score. The functions ψ1 and ψ0 correspond to the first and second ratios of the ATT
estimator (3.2), respectively.
Let ξ “ pα0, αT1 , µ1, µ0q
T and let ξ̂ “ pα̂0, α̂T1 , µ̂1, µ̂0q
T , where ξ̂ solves the estimating
equations
ř
i ψpYi, Ai, Li, α, µq “ 0 and zATT “ µ̂1 ´ µ̂0 is the ATT estimator in (3.2). Then
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under suitable regularity conditions (Stefanski and Boos, 2002)
?
npξ̂ ´ ξq Ñd Np0, V pξqq
where V pξq “ Apξq´1BpξqtApξq´1uT with Bpξq “ EtψpY,A, L, ξqψpY,A, L, ξqT u, Apξq “
Et´ 9ψpY,A, L, ξqu, and 9ψpY,A, L, ξq “ BψpY,A, L, ξq{BξT . It follows from the Delta method








where Σ “ ∇gpξqTV pξq∇gpξq is the asymptotic variance of the ATT estimator, ∇gpξqT “
p0, 0TJ , 1,´1q, and 0J is the 0 vector of length J . Let Σ̂ denote the consistent estimator for Σ ob-
tained by substituting V̂ pξ̂q for V pξq where the expectations in V are replaced by their empirical
counterparts and ξ̂ is substituted for ξ. Then in large samples the variance of zATT can be approx-
imated by Σ̂{n, which below is referred to as the stacked estimating equations (SEE) variance
estimator.
The derivation above considers the usual scenario in observational studies where the weights
are estimated. Now suppose instead that the weights are known, i.e., the values of the true weights
Wi “ Ai ` p1´ AiqhpLi;αq are known and therefore the propensity score need not be estimated.
Let zATT
˚
denote the estimator (3.2) with Ŵi replaced with Wi. Then, similar to above, it is
straightforward to show that zATT
˚












where p1 “ P pA “ 1q. Let Σ̂˚ represent the estimator for Σ˚ obtained by substituting the
expectations in (3.5) with their empirical counterparts and substituting µ̂ for µ, where α is known.
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Then Σ̂˚{n denotes the robust (Huber-White) sandwich variance estimator discussed at the end of
Section 3.2.1.
In Appendix B.1 it is shown that
Σ “ Σ˚ ` p´21 pc11 ` c22 ´ 2c12q (3.6)
where the explicit forms of the ckm, k,m P t1, 2u are given in the Appendix. In general, the
sign of the second term on the right side of the equality of (3.6) can be either positive or nega-
tive. Therefore, Σ˚ can be either larger or smaller than Σ, as shown via four simple examples
in the next section. This suggests that using Σ̂˚ may result in conservative or anti-conservative
inference.
3.2.3 Asymptotic Calculations
In this section Σ˚ and Σ are compared for four simple data generating processes. Table 3.1
contains variable definitions and relationships for the variable L, the exposure A, and the poten-
tial outcomes Y a, in each of four examples. In scenarios (i) and (ii) the variable L is binary, and
in scenarios (iii) and (iv) L is continuous (Normal). In all four scenarios, the exposure A is binary
and Y a is Normally distributed with a standard deviation of 0.5. The marginal exposure proba-
bility p1 and the population ATT value are also given in Table 3.1; these scenarios were chosen
because they do not involve rare exposures or extreme effect sizes.
Table 3.1: Distribution of L, exposure A, and potential outcome Y a for four different scenarios,
along with the marginal probability of exposure and the ATT. Bern(π) denotes Bernoulli
distribution with expectation π and Npµ, 1q indicates Normal distribution with mean µ and
variance 1.
Scenario L logittP pA “ 1|L “ lqu EpY a|L “ lq p1 ATT
(i) Bern(0.5) ´1´ 2 l ´1 a´ 1.5 l ` 1.5 a l 0.16 -0.78
(ii) Bern(0.3) 1` 0.1 l 1 a` 1.5 l ` 0.5 a l 0.74 1.15
(iii) N(0,1) 1` 0.1 l 1 a` 0.5 l ´ 1.5 a l 0.73 0.96
(iv) N(1,1) 1´ 1 l 1 a´ 1.5 l ´ 0.5 a l 0.50 0.71
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The asymptotic variances of zATT and zATT
˚
are shown in Table 3.2. The ratio of asymp-
totic standard deviations, i.e., pΣ{Σ˚q1{2, is also reported in Table 3.2 for sake of comparison
with the empirical results reported in Section 3.3 below. Note from Table 3.2 that Σ may be sub-
stantially smaller or larger than Σ˚. Thus even in large samples Σ̂ and Σ̂˚ may be quite different.
Moreover, Σ̂˚ will tend to yield anti-conservative inferences in scenarios (i) and (ii) and conserva-
tive inferences in scenarios (iii) and (iv). This is demonstrated empirically in the next section.
Table 3.2: The asymptotic variance of the ATT estimator when weights are unknown (Σ) and
known (Σ˚), and the ratio (Unknown / Known) of the asymptotic standard deviations (SD Ratio).
Scenario Σ Σ˚ SD Ratio
(i) 3.90 2.26 1.31
(ii) 1.36 4.33 0.56
(iii) 4.37 3.59 1.10
(iv) 11.28 24.50 0.68
3.3 Simulation Studies
For each scenario shown in Table 3.1, n “ 1, 000 i.i.d. copies of the variables L, A, and Y
were generated for each of 1,000 datasets. For each simulated data set, zATT was calculated using
weights estimated by fitting model (3.1). Standard errors were estimated using both pΣ̂{nq1{2 and
pΣ̂˚{nq1{2. The former can be obtained with the geex package in R (Saul and Hudgens, 2020) or
the CAUSALTRT procedure in SAS (SAS Institute Inc., 2018), and the latter is widely available
in various R packages (e.g., sandwich, geeglm) or using SAS procedures (e.g., REG, GENMOD).
The simulation study presented here and the data analysis in the following section were con-
ducted in R version 3.6.3 (R Core Team, 2020) with variance estimates computed using the geex
package. For each simulated data set Wald 95% confidence intervals (CIs) were constructed
using each SE estimate.
Results from the simulation study are presented in Table 3.3. In all scenarios CIs based on
Σ̂ achieved nominal coverage, whereas CIs constructed using Σ̂˚ either under- or over-covered.
These results are in agreement with the asymptotic derivations in Section 3.2. The average esti-
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mated SE (zASE) for both of the SE estimators was computed over the 1000 simulated data sets
for each scenario. The zASE ratios are reported in Table 3.3; as expected, these ratios are very
similar to the asymptotic SD ratios in Table 3.2.
Table 3.3: Average estimated standard error (zASE) using the stacked estimating equations (SEE)
and Huber-White (HW) variance estimates, 95% confidence interval coverage, and zASE ratio
(SEE/HW) for each simulated scenario.
Stacked Est Eqns Huber-White
Scenario ASÊ Coverage ASÊ Coverage ASÊ Ratio
(i) 0.062 0.95 0.048 0.87 1.31
(ii) 0.037 0.95 0.066 1.00 0.56
(iii) 0.066 0.95 0.060 0.93 1.10
(iv) 0.106 0.94 0.157 1.00 0.67
3.4 METSIM Data Analysis
3.4.1 Data Characteristics and Analysis
The METSIM cohort has been described and analyzed previously (Civelek et al., 2017;
Reifeis et al., 2020). Participants of this population-based study were Finnish men aged 45-
73, a subset of whom had RNA expression data recorded from an adipose tissue biopsy (n “
770) (Laakso et al., 2017). The exposure of interest A is current smoking (yes/no) and the out-
comes Yg, g “ 1, ..., 18, 510, are normalized adipose expression levels for each of 18,510 genes.
Each of these gene expression outcomes will be analyzed separately. The target of inference is
the ATT for each gene, i.e., the average effect of current smoking on that gene’s expression in
smokers. The set of variables L considered sufficient for satisfying the conditional exchange-
ability assumption were age, alcohol consumption, body mass index (BMI), exercise level, and
vegetable consumption.
The logistic regression model (3.1) of current smoking on the set of variables L was fit to
estimate the weights Ŵi for each individual. It is good practice to check that the mean of the
estimated weights is close to its expected value. For the ATT weights, the expected value is 2p1;
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see Appendix B.2 for details. The probability p1 is unknown here, but can be estimated by p̂1 “
ř
iAi{n. For the METSIM data, the mean of the estimated weights and the estimated expected
value of the weights were both 0.34. The IPW estimator of the ATT for each gene was computed
by fitting a separate linear regression model EpYg|Aq “ θg0 ` θg1A via weighted least squares
using the estimated weights. The same set of individuals and weights were used for each model.
Standard errors for the estimated ATTg were estimated using both Σ̂ and Σ̂˚.
3.4.2 Results
Figure 3.1a shows the ratio of the two estimated standard errors for each of the 18,510 genes,
where the vertical blue line indicates equality of the two standard error estimates. While most of
the SE estimates using Σ̂˚ were conservative (ratio less than one), there were hundreds of genes
for which the estimates were anti-conservative relative to Σ̂. The difference in SE estimates was
modest for most genes, but even small differences in SE estimates can substantially affect the
p-values. Figure 3.1b shows raw (i.e., unadjusted for multiple testing) p-values for Wald tests of
the null hypothesis H0 : θg1 “ 0 using either SE estimate. Only the 50 genes with the smallest
p-values are shown. The top 50 genes as ranked by p-value differed between the two approaches,
so there are 54 genes total represented in Figure 3.1b. Neither Σ̂˚ nor Σ̂ always resulted in larger
raw p-values, which aligns with the results displayed in Figure 3.1a. Choice of standard error
estimator resulted in very different p-values for some genes, with p-values often 2-3 times larger
or smaller when using Σ̂˚ compared to Σ̂.
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(a) (b)
Figure 3.1: (a) Ratio of estimated SEs computed using Σ̂ and Σ̂˚, for the ATT of each gene in the
METSIM data analysis. Vertical blue line at ratio value one denotes equality of the two SEs. (b)
P-values (unadjusted) for both methods of SE estimation, for each of the top 50 genes as ranked
by either method (54 genes depicted in total).
3.5 Discussion
In the context of variance estimation for the ATT estimator when using IPW, assuming the
weights are known can result in either a conservative or an anti-conservative variance estimate.
This finding is contrary to the well known result regarding variance estimation for the ATE,
namely that assuming the weights are known results in conservative variance estimates. Four
simple examples are provided demonstrating that standard error estimates may be substantially
larger or smaller depending on whether the weights are treated as known or estimated. Addition-
ally, power may be over- or under-estimated when computed using Σ̂˚. Analysis of the METSIM
data demonstrated how the different variance estimates can affect the ranking of genes and raw
p-values.
The variance estimator using stacked estimating equations is consistent, has a closed-form,
and can be easily computed using the geex package in R or the CAUSALTRT procedure in SAS.
R code for the asymptotic calculations in Section 3.2.3 is provided in the Web Appendix, along
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with a workflow for analyzing a simulated data set. The bootstrap is another approach to esti-
mating the variance of the IPW ATT estimator (Imbens, 2004; Abdia et al., 2017; Jawid and
Khadjavi, 2019; Were et al., 2017), but the bootstrap estimator does not have a closed-form and
can be computationally intensive.
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CHAPTER 4: CAUSAL INFERENCE FOR MULTINOMIAL OUTCOME WITH
TWO-PHASE OUTCOME-DEPENDENT SAMPLING DESIGN
4.1 Introduction
Two-phase outcome-dependent sampling designs are often utilized in observational studies,
and the data can be used to estimate exposure effects on an outcome of interest. These exposure
effects are subject to bias both from confounding and from unequal sampling. Confounding of
the relationship between the exposure and outcome is generally expected in observational studies,
and adjustments must be made for the biased sampling scheme when estimating these exposure
effects. The two phases of sampling are defined as follows. First, a simple random sample (SRS)
of individuals is drawn from a population; outcome data and other covariates are collected on
these individuals, and used to stratify them. Then a SRS is drawn from each stratum of the first
phase sample, with known stratum-specific selection probabilities; more data is collected on
the individuals selected for this second phase (Neyman, 1938). Inverse probability weighting
(IPW) has been used to estimate exposure effects for these study designs, accomplishing ad-
justment for both confounding and the biased sampling, but not in the context of a multinomial
outcome (Wang et al., 2009).
Outcome-dependent sampling is usually done with respect to a binary outcome, such as in
case-control studies. However, many disease outcomes are dichotomized for ease of analysis but
are not truly binary. For example, many subtypes of disease exist for particular cancers and it
may be of interest to researchers to compare exposure effects for these different subtypes. The
effect of a given exposure on cancer risk overall may be null, but its effect on certain subtypes
could be non-null, as it could confer an increase in risk for one or more subtypes, while a de-
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crease for others. Etiologic heterogeneity refers to the situation where different sets of events or
exposures may give rise to the different subtypes of disease, or more subtly that the degree of
risk conferred may differ across subtypes of disease. Such heterogeneity is a topic of increasing
interest in the field of cancer epidemiology (Zabor and Begg, 2017). The ability to determine
whether or not a given factor raises cancer risk for a particular subtype more than the others
can allow for identification of previously unknown relationships, and can help to generate new
mechanistic hypotheses. In particular, questions of interest about environmental risk factor effect
heterogeneity may be, for example, “Is there a difference in the effect of oral contraceptive use
on risk of developing luminal A breast cancer compared to triple negative? If so, how big is the
difference?”. In answering questions of this type, both point and interval estimates are required
for subtype-specific exposure effects as well as testing for equality of these effects. Knowledge of
these relationships could give insight into the underlying mechanisms of cancer etiology.
When considering risk factor effects on subtypes of disease, an important distinction must
be made between genetic and environmental risk factors. Geneticists performing genome-wide
association studies often rely on the assumption that the individuals in their study are not related,
or that approaches based on mixed models sufficiently capture relatedness due to ancestry differ-
ences in the population under study (Sul et al., 2018). Furthermore, in interpretation of genetic
associations, it is sometimes assumed that genetic risk factors are not influenced by other vari-
ables. One might assume no confounding of the relationship between the genetic risk factors and
disease subtypes: that other variables that may influence outcomes do not influence an individ-
ual’s chance of possessing a certain set of alleles. For example, Zhang et al. (2019a), Zhang et al.
(2019b), and Ahearn et al. (2019) have recently studied etiologic heterogeneity with genetic risk
factors using methods directly from or based on work by Chatterjee (2004). On the other hand,
environmental risk factors and exposures are often influenced by many other variables. As a re-
sult, confounding can generally be expected when estimating environmental exposure effects on
disease subtypes from observational data. Zabor and Begg (2017) compares statistical methods
from Chatterjee (2004), Rosner et al. (2013), and Wang et al. (2015) that were developed for
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investigation of etiologic heterogeneity, and illustrates them with a real data example involving
an environmental risk factor. These methods allow for incorporating confounding adjustment via
including confounders as predictors in a regression model. Benefield et al. (2019) estimated vari-
ous environmental exposure effects on subtypes of breast cancer using regression, with a similar
approach to confounding adjustment. Note that these methods involve the strong assumption that
the confounders and exposure do not interact to influence the outcome. Additionally, IPW has
been used for estimation of exposure effects on multinomial outcomes (Richardson et al., 2018),
but not in the context of outcome-dependent sampling. When estimating exposure effects in this
context, methods are still needed that can accomplish each of (i) appropriately adjusting for con-
founding, (ii) accounting for the sampling design, and (iii) leveraging the multinomial nature of
the outcome to answer questions of exposure effect heterogeneity.
4.2 Methods
Consider a two-phase outcome-dependent sampling design where the goal is to estimate the
effects of a binary exposure A on a multinomial outcome Y , where Y takes values k “ 0, ..., K
and K ě 1. Let L “ pL1, L2q where L1 and L2 denote the set of covariates observed for all
first and second phase individuals, respectively. Let Yk be an observed indicator of experiencing
event subtype k, k “ 0, ..., K, where k “ 0 denotes no event. Note that Y “
řK
k“1 kYk. Now
let Y a and Y ak denote counterfactual event subtype and the indicator of event subtype k, respec-
tively, under exposure a, a “ 0, 1. Let S be an indicator of selection for the second phase, and
gpY, L1, Aq “ P pS “ 1|Y, L1, Aq represent the known selection probabilities. In the first phase
of sampling, let the observed data be denoted pL1i, Yi, Aiq i.i.d., i “ 1, ...,m. For the second
phase of sampling, the observed data Oi “ pL1i, SiL2i, Yi, Ai, Siq is i.i.d., i “ 1, ...,m. Assume
S K L2 | Y, L1, A, i.e., conditioning on the variables that influence an individual’s probability
of selection, selection is independent of the covariates observed in the second phase of sampling.
Let
řm
i“1 Si “ n denote the number of individuals selected in the second phase of sampling.
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Let πak “ P pY
a “ kq represent the probability of subtype k “ 1, ..., K had, possibly




j for a “ 0, 1. Let
eapLq “ P pA “ a|Lq represent the probability of an individual receiving exposure level a given
the value(s) of their covariate(s) L, for a “ 0, 1. Finally, let Wi “ W pOiq “ SitAi{e1pLiq `
p1 ´ Aiq{e0pLiqu{gpYi, L1i, Aiq represent the weights used for IPW. Assume Y a K A | L for
a “ 0, 1 (conditional exchangeability), Y “ AY 1 ` p1´ AqY 0 (causal consistency) and eaplq ą 0
for all l where dFLplq ą 0 and FL is the CDF of L and a “ 0, 1 (positivity). Also assume that
every individual has a nonzero sampling probability, i.e., gpy, l1, aq ą 0 for all y, l1, and a where
dFY,L1,Apy, l1, aq ą 0 and FY,L1,A is the joint CDF of Y , L1, and A.
There are various potential estimands of interest to consider when asking questions of etio-
logic heterogeneity. Risk factor or exposure effects can be defined in different ways, depending
on the research question. Some estimands are covariate-conditional, meaning that the estimands
are conditional on particular values of the covariates L. This type of conditionality may not be de-
sirable, particularly when the researcher’s question is best answered by estimating a single quan-
tity describing the population of interest. All estimands considered here are subtype-conditional,
meaning that the estimand for each subtype k is conditional on the outcome being subtype k or
no disease. This quality is desirable for interpretability of the estimand, and it facilitates compar-
isons between subtypes of disease. For the models presented below, relative risk ratios (RRRs)
are considered, which may also be referred to as subtype-conditional odds ratios (ORs). Alter-
natively, one may choose to model the multinomial outcome categories separately with a series
of binary regression models. This approach may or may not result in subtype-conditional ORs,
depending on how the outcome reference group is defined for each model. While this approach
may be appealing for ease of implementation in software, modeling separately does not allow
for estimation of the covariances between the ORs. Therefore, formal comparisons of multiple
subtypes are not possible when modeling separately and this approach will not be considered
further.
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4.2.1 Inverse Probability Weighting







“ β1k ` β2ka, k “ 1, ..., K






j qu with ρ
a
k “ β1k ` β2ka and define ρ
a
0 “ 0 and
β “ pβ11, β21, ..., β1K , β2Kq. The parameter β2k can be interpreted as a log RRR, or a log subtype-






0q represents the causal RRR of devel-
oping subtype k relative to control had everyone been exposed vs. unexposed. Put another way,
exppβ2kq represents the causal subtype-conditional OR of developing subtype k had everyone
been exposed vs. unexposed. Hereafter this will be referred to as the exposure effect for subtype
k.
Let eapLq be estimated by eapL; α̂q as described in Appendix C.1.1. Then the IPW weights
Wi can be estimated by Ŵi “ W pOi; α̂q “ SitAi{e1pLi; α̂q ` p1 ´ Aiq{e0pLi; α̂qu{gpYi, L1i, Aiq.
In particular, consider the following multinomial logistic regression model, which can be fit using






“ β˚1k ` β
˚
2kA, k “ 1, ..., K (4.1)
where πk “ P pY “ k|S “ 1, Aq represents the probability of developing subtype k among the
selected given A, for k “ 1, ..., K, and π0 “ 1´
řK
j“1 πj . Let β













2Kq represent the maximum likelihood estimator (MLE) of β
˚. Fitting
model (4.1) by maximizing the weighted likelihood with estimated weights Ŵi yields, for all k,
the estimator β̂˚, which is consistent for β and asymptotically normal; see Appendix C.1.2 for
details.
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Both the Taylor Series (TS) (Binder, 1983) and nonparametric bootstrap (Mashreghi et al.,
2016) methods can be used to estimate the covariance matrix while appropriately accounting for
biased sampling. Neither of these methods account for estimation of the weights, so an additional
nonparametric bootstrap estimator accounting for IPW weight estimation can be used. In the set-
ting described here, the TS estimator is consistent for the covariance matrix when the propensity
score is known and can be equivalent to the Huber-White “robust” sandwich variance estimator;
see Appendix C.1.3 for details. The bootstrap estimators are evaluated empirically in Section
4.3. Variance estimates of the estimated subtype-conditional ORs can then be used to construct
Wald confidence intervals (CIs). Finally, F -tests may be used for formal comparisons of subtype-
conditional ORs (SAS Institute Inc., 2017). For example, the test of no exposure effect hetero-
geneity across subtypes of disease may be of interest, i.e., the test of H0 : β21 “ ... “ β2K . The
Wald test statistic WF “ pRβ̂˚qT tRΣ̂pβ̂˚qRT u´1pRβ̂˚q can be computed, where R is a contrast
matrix with K ´ 1 rows representing the structure of the null hypothesis and Σ̂ is the estimated
covariance matrix evaluated at β̂˚. Then since Wf
d
ÝÑ F pK ´ 1, n ´K ` 1q, the F -test may be
used for the test of no heterogeneity. Similarly, the researcher may wish to compare subtypes j
and k only by using the F -test of H0 : β2j “ β2k; this reduces to testing the equivalence of the
relative risks of subtypes j and k due to the common denominator of the β2k, k “ 1, ..., K.
4.2.2 Regression with Sampling Weights or Offsets
Let X represent a design matrix with rows Xi “ p1, Ai, L1i, L2iq for each individual i. Con-
sider the following multinomial regression model
log
ˆ
P pY “ k|Xq
P pY “ 0|Xq
˙
“ Xλk, k “ 1, ..., K (4.2)
where λk “ pλ1k, λ2k, λ3k, λ4kq is a column vector and λ “ pλT1 , ..., λ
T
Kq. Since the OR is not gen-
erally collapsible over levels of the covariates L, λ2k and β2k are not equivalent in general. Note
that interaction terms are omitted from this model, in effect assuming there are no interactions
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between the exposure A and covariates L that influence the outcome. When interactions between
A and L are included, λ2k represents the subtype-conditional and covariate-conditional OR of
developing subtype k for the exposed vs. unexposed, conditional on all variables L taking value
zero.
This model cannot be fit directly with the observed information because of the biased sample
selection. The selection weight for an individual i is defined as the inverse of their sampling
probability, i.e., 1{gpYi, L1i, Aiq, which is known by design; see Appendix C.1.4 for details. The
offset term for an individual i with L1i “ l1 and Ai “ a can be expressed as
Xiω “ log
ˆ
gpYi “ k, L1i “ l1, Ai “ aq
gpYi “ 0, L1i “ l1, Ai “ aq
˙
(4.3)
and is known by design since it is a function of the known sampling probabilities. Here ω is a
known vector relating an individual’s covariate values to their offset term. It is assumed when
constructing the offset term that selection is performed with respect to dichotomized outcome
where 0 is the reference category and the selection probability for all subtypes k “ 1, ..., K
are equal; see Appendix C.1.5 for details. Consider the following model that can be fit with the






“ Xλ˚k, k “ 1, ..., K (4.4)
where π̃k “ P pY “ k|S “ 1, A, Lq represents the probability of developing subtype k among
the selected given A and L, for k “ 1, ..., K, and π̃0 “ 1 ´
řK











a column vector, and λ˚ “ pλ˚T1 , ..., λ
˚T
K q. Let λ̂
˚ “ pλ̂˚1 , ..., λ̂
˚
Kq and λ̃
˚ “ pλ̃˚1 ´ ω, ..., λ̃
˚
K ´ ωq
represent the MLEs of λ˚ when fitting model (4.4) with sampling weights and the offset term,
respectively. Then λ̂˚ and λ̃˚ are consistent for λ and asymptotically normal; see Appendices
C.1.4 and C.1.5 for details.
As with IPW, variance estimation for the regression approaches can be carried out with the
TS and nonparametric bootstrap methods. The TS estimator is consistent for the covariance
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matrices for the regression methods, and again the bootstrap estimator is evaluated empirically
in Section 4.3. As there is no weight estimation for the regression approaches, no additional
bootstrap estimators are used. Again, Wald CIs for the estimated subtype-conditional ORs can
be constructed using the variance estimates computed by these methods. Similarly, F -tests of
any null hypothesis of interest that can be expressed as a contrast of model parameters may be
performed.
4.2.3 Simulation Studies
Phase one data sets of size 20,000 and 200,000 were simulated for each scenario. The out-
come Y was multinomial with three levels (0, 1, 2) where zero was selected as the reference level,
and the exposure A was binary. Five hundred samples of size 2,000 were drawn from each of the
first phase data sets, resulting in sampling percentages of 10% and 1% for the data sets of size
20,000 and 200,000, respectively. The sampling weights were dependent on one binary covariate
L1 and the dichotomized outcome Y (0 vs. 1 or 2), but not the exposure A, and were defined such
that half of the observations within each second phase data set had Y “ 0. One second phase
covariate L2 was generated with a Poisson distribution, and the set L “ pL1, L2q was sufficient
for confounding adjustment. Subtype-conditional ORs and their corresponding confidence inter-
vals were computed for subtypes 1 and 2, using each of the methods described in Section 4.2. All
analyses here and in the following section were conducted with SAS software, Version 9.4 using
the SURVEYLOGISTIC procedure (SAS Institute Inc., 2017) and the %BOOT macro.
The empirical bias of the ORs and 95% CI coverage and width are given in Table 4.1, and
the results are aggregated over 500 simulated data sets. Each OR estimator’s variance was es-
timated using Taylor Series and bootstrap estimators. For the IPW estimator, the variance was
estimated using the bootstrap estimator with and without accounting for estimation of the stabi-
lized weights. All bootstrap variance estimates were computed using 250 replicates.
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4.2.4 CBCS Analysis
The methods described above were applied to the Carolina Breast Cancer Study (CBCS)
Phase I-II data for estimation of subtype-conditional effects of several exposures on breast cancer.
These data have been described and analyzed previously (Newman et al., 1995; Benefield et al.,
2019). Phase I (1993-1996) and II (1996-2001) of CBCS are population-based case-control stud-
ies, where “Phase” here refers to the distinct time periods over which the CBCS was conducted
and does not indicate phase with respect to two-phase outcome-dependent sampling. Individuals
with breast cancer (“cases”) were recruited into CBCS from the North Carolina Central Cancer
Registry, and individuals without breast cancer (“controls”) were recruited from Department of
Motor Vehicles (DMV) and Medicare records. Age, race, and breast cancer status was known for
all individuals in these records. Breast cancer subtype, exposures, and other covariate information
were not recorded in the cancer registry, DMV, or Medicare records, and thus were only obtained
for those individuals selected into the CBCS. Note the CBCS data does not fit exactly into the
two-phase outcome-dependent sampling framework, and an additional assumption was neces-
sary. Specifically, it was assumed that the individuals on the cancer registry and the DMV and
Medicare records constituted a random sample of the population of women from central North
Carolina. This assumption allowed these individuals to comprise the first phase sample from the
two-phase outcome-dependent sampling framework. Assuming this, it follows that the random
sampling done for CBCS from the aforementioned registries and records (within groups defined
by study Phase [I or II], age, race, and breast cancer status) fit the definition for the second phase
of sampling in this framework. Further consideration of potential violations of this assumption
are considered in the Discussion section.
Breast cancer subtypes were defined here as in Benefield et al. (2019), namely based on es-
trogen receptor (ER) status (positive or negative) and tumor suppressor gene p53 status (positive
or negative) obtained from processing the breast tumor sample. The dichotomized exposures
considered were BMI (ě 25 / ă 25), breastfeeding (ever/never), oral contraceptive use (ever/n-
ever), and parity (parous/nulliparous). The selection probabilities were fixed by study design and
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were dependent on study Phase (I or II), age, race, and breast cancer status. Note that in Section
4.2 these probabilities were allowed to depend on the exposure A, but for the CBCS data they
are not dependent on any of the exposures considered. For all exposures considered, the set of
variables assumed sufficient for confounding adjustment included age, race, and age at menarche.
For parity and breastfeeding, this set also included BMI and oral contraceptive use. For BMI,
this set also included oral contraceptive use. For oral contraceptive use, this set also included par-
ity. Missing data were assumed to be missing at random, and complete data on 2789 individuals
(pooled over Phases I and II) were analyzed.
4.3 Results
4.3.1 Simulation Studies
Simulations of studies following outcome-dependent sampling designs were generated and
evaluated in order to determine the extent of bias and interval coverage across the approaches
outlined above. Results presented in Table 4.1 represent data generated such that 1% of observa-
tions were selected from the first phase; results for 10% sampling are located in Appendix C.2.
The first scenario represents a case with no confounding, and the bias, coverage, and CI widths
were comparable across all methods evaluated, as expected. The second scenario represents a
case with confounding including interactions between the exposure A and the covariates L. The
regression methods showed substantial bias and poor coverage for the subtype-conditional OR
for subtype 1 (OR1), also as expected, but not for subtype 2 (OR2). The IPW estimator showed
small or zero bias and nominal CI coverage. Small or zero bias and nominal CI coverage in the
presence of confounding with interactions is not expected of the regression estimators in general,
but is expected of the IPW estimator. CI width was similar across methods within each scenario,
with the exception that the CI widths for the IPW estimator with any variance estimator appeared
smaller than for either regression estimator.
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Table 4.1: Average empirical bias and 95% confidence interval (CI) coverage and width for the
regression estimators using offsets (Reg Offset) and sampling weights (Reg Wts), and the IPW
estimator. Variances of these estimators were estimated using the Taylor Series (TS) and
bootstrap (Boot) variance estimators, and for IPW the bootstrap estimator accounting for
propensity score estimation (Boot+PS) is also shown. Results are given for both the subtype
conditional OR for subtype 1 (OR1) and subtype 2 (OR2). Scenarios shown are for 1% sampling
proportion of first phase observations into second phase. Empirical bias values larger than 0.1
and 95% CI coverage values less than 0.90 are underlined.
Scenario Method Variance Bias Coverage CI Width
Est Method OR1 OR2 OR1 OR2 OR1 OR2
OR1 “ 1.00, IPW Boot+PS 0.03 0.01 0.97 0.94 0.96 0.43
OR2 “ 1.00, Boot 0.97 0.95 0.97 0.43
No confounding TS 0.97 0.94 0.95 0.43
Reg Wts Boot 0.03 0.01 0.97 0.95 0.97 0.43
TS 0.97 0.95 0.95 0.43
Reg Offset Boot 0.03 0.01 0.96 0.95 0.95 0.42
TS 0.96 0.95 0.93 0.42
OR1 “ 0.86, IPW Boot+PS 0.00 0.01 0.95 0.96 0.35 0.30
OR2 “ 0.18, Boot 0.97 0.97 0.40 0.30
Confounding TS 0.97 0.96 0.40 0.28
with interactions Reg Wts Boot 0.27 0.01 0.32 0.97 0.49 0.30
TS 0.32 0.95 0.49 0.29
Reg Offset Boot 0.19 0.03 0.56 0.96 0.46 0.33
TS 0.58 0.95 0.46 0.31
4.3.2 CBCS Analysis
The CBCS data was used as a case study for evaluating differences in the subtype-conditional
exposure effect estimates for BMI, breastfeeding, oral contraceptive use, and parity. Figure 4.1
displays the estimated ORs and 95% CIs for each exposure of interest using each method out-
lined in Section 4.2 above. The variances for the estimated subtype-conditional ORs from each
method were estimated using both the Taylor Series and nonparametric bootstrap estimators, as
well as the bootstrap estimator accounting for propensity score estimation for the IPW estimator.
For each of the exposures considered, the variability of the regression estimator with offsets is
smaller than the variability of the other estimators. The variance estimation methods performed
similarly within each subtype-conditional OR estimator. Slight differences in subtype-conditional
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OR estimates and their estimated variances were observed across methods, with the most pro-
nounced differences occurring for parity.
Figure 4.1: Subtype-conditional odds ratios and 95% confidence intervals (CIs) for BMI
(referent: ă 25), breastfeeding (referent: never), oral contraceptive (OC) use (referent: never),
and parity (referent: nulliparous). Odds ratios and CIs are estimated using each of the methods
presented in Section 4.2.
Table 4.2 gives p-values for the test of no heterogeneity of exposure effect across breast
cancer subtypes, for each of BMI, breastfeeding, oral contraceptive use, and parity. Specifically,
each p-value corresponds to the F-test of H0 : OR´´ “ OR´` “ OR`´ “ OR`` for the
given exposure, where OR´` represents the subtype-conditional OR for subtype ER-/p53+, and
ORs for the other subtypes are defined analogously. Overall, none of the p-values for the test of
heterogeneity were less than 0.05 but there were some substantial differences between methods.
For parity, p-values corresponding to IPW with each of the variance estimates were several times
larger than p-values corresponding to the other approaches. For breastfeeding, the regression with
offset approach yielded the largest p-values. Within each modeling approach, variance estimation
methods performed similarly for each exposure.
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Table 4.2: P-values for the test of no heterogeneity across subtypes for each of BMI,
breastfeeding, oral contraceptive (OC) use, and parity.
Method Var. Est. BMI Breastfeeding OC Use Parity
IPW Boot+PS 0.98 0.26 0.75 0.60
Boot 0.97 0.25 0.65 0.58
TS 0.97 0.25 0.69 0.52
Reg Wts Boot 0.77 0.29 0.68 0.27
TS 0.75 0.26 0.71 0.21
Reg Offset Boot 0.71 0.57 0.90 0.09
TS 0.70 0.47 0.87 0.07
4.4 Discussion
In the context of two-phase outcome-dependent sampling, regression with sampling weights
or offsets will not yield valid inference in general in the presence of confounding with interac-
tions between exposure A and covariates L. This was demonstrated in the simulation studies,
where the regression approaches at times showed substantial bias of the OR estimator and poor
CI coverage. For CBCS, similar results were observed across methods for BMI, breastfeeding,
and oral contraceptive use, but substantial differences were observed across methods for par-
ity. All models considered here modeled subtypes together, and while outcome subtypes may
be modeled separately this approach doesn’t allow for estimation of the covariances between
the subtype-conditional ORs. Thus, the variance cannot be estimated for contrasts involving
multiple subtype-conditional ORs. That is, CIs and hypothesis tests for these contrasts are not
available without estimating the ORs for all subtypes simultaneously. Fitting the multinomial
models described in Section 4.2 facilitate simultaneous estimation, allowing for estimation of the
covariance matrix and therefore testing null hypotheses involving multiple subtype-conditional
ORs. Further, applying IPW in this setting allows for answering questions of effect heterogeneity,
yielding valid inference in the presence of confounding and biased sampling.
The moderate sample size of CBCS is a limitation, particularly in that certain breast cancer
subtypes are rare and therefore the number of individuals with certain subtypes is small. Also, the
CBCS sampling weights were defined such that there were several orders of magnitude between
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the largest and smallest weights. Extreme weights can lead to issues with model convergence.
In the CBCS analysis, it was assumed that the cancer registry, Medicare, and DMV records data
constituted a random sample from the population of women in central NC. If the individuals not
included in these records were systematically different than those included in the records, the
sample would be biased in a manner that is not adjusted for by the methods presented. Then the
OR estimators from each of the methods may be biased and not appropriately describe the effects
of the exposures considered in the population. Additionally, the assumption that the variables L
were sufficient for confounding adjustment in each of the CBCS analyses may not hold, and this
could also result in invalid inference using each of the methods considered. Areas for future work
include utilizing all of the observed information to improve efficiency, instead of just the informa-
tion for individuals selected into the second phase. In particular, the last three methods presented
in Wang et al. (2009) for two-phase outcome-dependent sampling may be adapted to the multino-
mial outcome setting. Additionally, further investigation of the potential consequences of extreme
sampling weights and violations (or near-violations) of positivity is desirable.
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CHAPTER 5: CONCLUSIONS AND FUTURE RESEARCH
In this dissertation, we focused on methods and best practices for answering important re-
search questions posed by genomics and epidemiology researchers. Specifically, we considered
approaches for answering these questions with observational data, where the exposure-outcome
relationship may be influenced by confounding and biased sampling. Each chapter has high-
lighted issues with commonly applied approaches for drawing inferences in these settings, and
has demonstrated the validity of existing or newly extended alternate approaches. Through care-
ful illustration, we have demonstrated in Chapter 2 that existing causal methods such as inverse
probability weighting (IPW) and the parametric g-formula can be used for drawing valid infer-
ence on exposure effects with observational genomics data; these methods appropriately adjust
for confounding where the conventional regression approach may not. In Chapter 3, we took a
closer look at variance estimation for the IPW estimator of the exposure effect in the exposed
used in Chapter 2. In particular, we showed that the variance assuming the weights are known
(Σ˚ from equation (3.5)) can be smaller or larger compared to the variance accounting for weight
estimation (Σ from equation (3.6)). Since the weights often must be estimated, using the variance
estimator Σ̂˚{n may result in conservative or anti-conservative inference, unlike the consistent
estimator Σ̂{n of Σ. The methods in Chapters 2 and 3 were applied to data from the Metabolic
Syndrome in Men Finnish cohort to investigate questions regarding the effect of smoking on gene
expression in the smokers. Finally, in Chapter 4 we extended existing IPW methodology for in-
ference on exposure effects from two-phase outcome-dependent sampling studies to the setting
where the outcome is multinomial. We showed that this approach yields valid inference in the
presence of both confounding and biased sampling, whereas common regression approaches can
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yield biased exposure effect estimates and confidence intervals with coverage substantially below
nominal levels. The methods described and compared in Chapter 4 were applied to data from the
Carolina Breast Cancer Study to explore questions of heterogeneity of exposure effects on inci-
dence of breast cancer subtypes. We hope that researchers will find the works in these chapters
useful and practical for drawing valid inference on exposure effects using observational genomics
data, and we briefly consider various potential avenues for future work toward this end below.
In the Discussion section of Chapter 2, we briefly mentioned that doubly robust estimators
have demonstrated advantages in many contexts over both IPW and the parametric g-formula
(Lunceford and Davidian, 2004; Moodie et al., 2018; Naimi and Kennedy, 2017). In particular,
correct specification of the propensity score model is assumed for IPW and the outcome model
is assumed for the parametric g-formula; misspecification of these models may lead to invalid
inference. Doubly robust estimators, on the other hand, combine the strengths of IPW and the
parametric g-formula by allowing for valid inference when either the propensity score model or
the outcome model are misspecified. Future work could entail a thorough investigation of several
existing doubly robust estimators for application to the setting of observational genomics data.
Showing these doubly robust estimators result in valid inference in this setting and supplying
user-friendly software or workflows could have a positive impact on uptake of causal methods in
a wider community of researchers. This would give researchers another tool that could be used to
make valid inferences on exposure effects, and one that retains the desirable properties of and is
more robust than IPW or the parametric g-formula.
The result presented in Chapter 3 was demonstrated for simulated data and in a real data anal-
ysis, but it remains to be shown what contributes to Σ˚ taking larger or smaller values compared
to Σ. Specifically, future work could probe the relationship between these quantities further to
determine under what circumstances Σ̂˚ will yield conservative and anti-conservative inferences.
Procedures for estimating Σ are generally less available in standard software than those for esti-
mating Σ˚, and further characterization of the relationship between these variances could inform
a researcher’s choice of whether or not to take the additional step necessary to compute Σ̂. This
59
decision may be of practical importance to the researcher with respect to computing time, particu-
larly when the data sets or number of outcomes being analyzed are very large, as is often the case
with genomics data. Alternatively, efforts could be made to make computing procedures for Σ̂
more widely available and efficient.
As mentioned in the Discussion section of Chapter 4, future work could seek to develop new
or extend existing estimators that use data collected on the individuals selected into the first phase
but not the second phase. One potential avenue for this would be extending the estimators pre-
sented in Wang et al. (2009) that leverage this information. These estimators may yield efficiency
gains over the IPW estimator presented in Chapter 4 by utilizing all available information. Addi-
tionally, in the spirit of Chapter 3, the relationship between the bootstrap variance estimators for
IPW could be explored further to determine whether or not the variance estimator must account
for weight estimation to yield valid inference in general.
Another area of future work for the ideas presented in Chapters 2 and 4 is the extension of
the methods presented to the setting where the exposure is continuous or longitudinal. In both
chapters, only settings where the exposure is binary and recorded for a single time point are
considered. Continuous exposures have been explored previously in the simple random sampling
setting using IPW (Naimi et al., 2014) and the parametric g-formula (Moore et al., 2012), and
future work could explore validity and feasibility of these methods in the observational genomics
setting. IPW with continuous exposures has also been investigated in the outcome-dependent
two-phase sampling setting (Hejazi et al., 2020), but not when the outcome is multinomial, and
thus future research may consider extending Chapter 4 methods to accommodate continuous
exposures. Longitudinal exposures have also been discussed using the parametric g-formula by
Neugebauer and van der Laan (2006); Taubman et al. (2009) and using IPW by Bodnar et al.
(2004) and others. Several possibilities exist for extending these previous works and the work in
Chapters 2 and 4 to settings where these different types of exposures are of interest.
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APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 2
A.1 Equivalence of g-formula estimator and Snowden’s g-computation algorithm
Proof that the g-formula estimation method presented in this paper is equivalent, in this
setting, to the g-computation algorithm outlined by Snowden et al. (2010) for both the ATE and
the ATT.
Let Y be an outcome variable and A be a binary treatment variable. Assume L is a vector of
length J which represents a sufficient set for confounding adjustment. Consider the following
linear model





where β2, β3 are parameter vectors of length J . Model A.1 is assumed to be correctly speci-
fied. The parameter estimates β̂ “ pβ̂0, β̂1, β̂T2 , β̂
T
3 q








β0 ` β1Ai ` β
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where β “ pβ0, β1, βT2 , β
T
3 q
T . The Snowden g-formula estimator for the ATE is obtained us-
ing the parameter estimates β̂ “ pβ̂0, β̂1, β̂T2 , β̂
T
3 q
T to compute the predicted values under the
counterfactual scenarios of no treatment (a “ 0) and treatment (a “ 1) for all. Specifically, let
Ŷ a “ Xaβ̂ denote the vector of predicted values for each individual under the counterfactual
scenario that all individuals receive treatment a, and where the design matrix Xa has rows of the




i s for i “ 1, ..., n and a “ 0, 1. The Snowden g-formula estimator of
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where L̄ is a vector of length J with elements equal to the sample means of the J confounding
variables.
Now, let L̃i “ pLi ´ L̄q and γ “ pγ0, γ1, γT2 , γ
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3 . This optimization problem is then equivalent to solving A.2 above, which yields the
usual least squares estimator β̂ “ pβ̂0, β̂1, β̂T2 , β̂
T
3 q









3 . That is, γ̂1 “ β̂1 ` β̂
T
3 L̄. Note that γ̂1 is the estimated exposure
coefficient from the g-formula model proposed in the Supplementary Methods for the ATE, and
the right side of this equality is exactly ˆATES from above. The equivalence of the two g-formula
estimators has thus been shown for the ATE.
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The equivalence proof for the ATT estimators is analogous to the ATE proof above. Wang
et al. (2017) propose an extension of Snowden et al.’s g-computation algorithm for the ATT; they
show that by restricting Xa to only the treated individuals (i.e., those with A “ 1), the algorithm
returns a consistent estimate of the ATT. In particular, let Ŷ a, A“1 “ Xa, A“1β̂ denote the vector
of predicted values for the n1 individuals with A “ 1 under the counterfactual scenario that
these individuals receive treatment a, and where the design matrix Xa, A“1 has n1 rows with the
same form given above. Here β̂ remains the usual least squares estimator found by solving A.2
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where L̄˚ is a vector of length J with elements equal to the sample means among the treated of
the J confounding variables.







T , and consider finding






















Rearranging this optimization problem similarly to A.3 and reparameterizing analogously to
above yields γ̂˚1 “ β̂1 ` β̂
T
3 L̄
˚. Note that γ̂˚1 is the estimated exposure coefficient from the g-
formula model proposed in the Supplementary Methods for the ATT, and the right side of this
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equality is exactly ˆATT S from above. Thus the equivalence of the two g-formula estimators has
been shown for the ATT as well.
The proof for the equivalence of the average treatment effect in the untreated (ATU) is simi-
lar to the proof for the ATT.
A.2 Supplementary Methods
A.2.1 Data Preprocessing
Microarray data (Affymetrix Human Genome U219 Array) from the METSIM project (Laakso
et al., 2017) was downloaded from GEO accession GSE70353 (Civelek et al., 2017) using the
Bioconductor package GEOquery (Davis and Meltzer, 2007). The downloaded data was normal-
ized by the study authors. Microarray measurements per probeset were summarized for each
gene using the median polish method from Tukey (1977) (the medpolish function in the R
programming environment) on log2 transformed, normalized expression data.
In general, missing covariate values in the data set must be addressed before employing
regression, IPW, or the parametric g-formula. If the percentage of individuals with missing co-
variates is low and the data are believed to be missing completely at random (MCAR), then a
complete case analysis may be expected to not introduce bias. However, it is rarely the case that
both of these criteria are met, and so it is recommended to take a more sophisticated approach
such as multiple imputation (Moodie et al., 2008; Perkins et al., 2018). For further details and
recommendations on handling missing covariates data when fitting causal models, see Moodie
et al. (2008).
Assume for all of the following models that expression level for gene g has been log2 trans-
formed and normalized, and that all probe sets have been collapsed (e.g., using median polish)
resulting in one measure per gene per subject. All vectors are assumed to be column vectors
throughout.
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A.2.2 Comparing Approaches for Exposure Effect Estimation
Let Yg represent the observed expression level for gene g and A be a binary exposure of in-
terest taking on values 0 or 1. For a “ 0, 1, let Y ag denote the expression level for gene g had,
possibly counter to fact, the exposure level been a. These Y ag are often referred to as counterfac-
tuals or potential outcomes, and only at most one of the potential outcomes Y 1g and Y
0
g for gene
g are observed for any given individual. The target of inference here is the ATT for gene g and
is defined as ATTg “ ErY 1g ´ Y
0
g |A “ 1s, the average effect of the exposure on expression





g s, the average effect of the exposure on expression for gene g in the population
of all individuals. The methods outlined below use the observed data to estimate exposure effects
on gene expression, and the assumptions sufficient for valid inferences on ATTg for each of these
methods are parsed out further in the remaining sections of the Supplementary Methods.
A.2.2.1 Regression
For modeling observed expression level Yg of gene g as a function of some exposure of in-
terest A in the presence of confounding, linear regression is the conventional approach. Con-
founders L, where L is a vector of length J , were included in the model as covariates along with
the exposure variable A. In particular, the model can be written
ErYg|A,Ls “ θg0 ` θg1A` θ
T
g2L (A.4)
for each gene g, where θg2 is also a vector of length J . The estimated exposure effect θ̂g1 and
its estimated standard error were computed in the usual fashion using ordinary least squares
(OLS). The estimator θ̂g1 in A.4 is interpretable as estimating the ATE for gene g, which does not
necessarily equal the ATT for gene g, unless operating under the assumption ATEg “ ATTg.
The omission of interaction terms from model A.4 assumes the exposure and confounders
are not interacting to influence gene expression, which is not necessarily true in general. There-
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fore if any such interactions are present in the data, this regression model will not account for
those relationships and can then yield biased exposure effect estimates. On the other hand, as
noted in the Discussion section, the inclusion of interaction terms yields conditional exposure
effects. Specifically, there is no one parameter in the regression model with interactions that is
interpretable as the ATT. If exposure-confounder interactions are included in model A.4, then the
estimated coefficient of the exposure variable estimates the exposure effect for an individual with
confounder variable values all equal to zero. This quantity does not describe the average exposure
effect in the population, and depending on the range of values for the included confounding vari-
ables, it may not even be close to describing the exposure effect for any people in the population.
For these reasons, neither the regression model with nor without interactions will yield consistent
effect estimates in general. The one exception where regression with interactions can consistently
estimate the ATT is when all confounders are centered at the mean in the treated, which is exactly
the g-formula; for further details see the Parametric g-formula section below and Appendix A.1.
Since this manuscript is focused on marginal exposure effects, interactions were omitted from the
regression model in the main text. However, results of fitting the regression model with interac-
tions are included later in the Supplementary Results section for both the simulated and METSIM
data.
A.2.2.2 Inverse Probability Weighting
Inverse probability weights were computed by fitting the following logistic regression model
with the binary exposure A as the outcome and the set of J confounders L as the predictors:
logitpP pA “ 1|Lqq “ α0 ` α
T
1 L (A.5)
where α1 is a vector of length J . The fitted values from this logistic regression model were
used to construct the individual weights that were then used in the models for gene expres-
sion. Choice of weights depends on the target population; this paper focuses on the ATT, so
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the weights given below first derived in Sato and Matsuyama (2003) were used. These weights
take the form for each individual i of the ratio of the conditional probability of the subject being
exposed to the conditional probability of the subject’s actual exposure status. That is, the weight
for subject i equals
WATTi “ Ai ` p1´ Aiq exppα0 ` α
T
1 Liq (A.6)
So, if a subject was exposed their weight was simply equal to one. For unexposed subjects,
weights were estimated by substituting in the estimates α̂0, α̂1 from fitting model A.5 for the
true parameter values in A.6, i.e., ŴATTi “ Ai ` p1 ´ Aiq exppα̂0 ` α̂
T
1 Liq. When using IPW it
is good practice to check that the mean of the weights is close to their expected value; for these
weights, ErWATTi s “ 2P pA “ 1q.
After estimating the weights, the linear regression model
ErYg|As “ θg0 ` θg1A (A.7)



















This estimator is sometimes referred to as the Hajek or modified Horwitz-Thompson estima-
tor (Hernán and Robins, 2020), and is consistent for ATTg. Note that consistency of the Hajek
estimator depends on the model for A|L in A.5 being correctly specified. No outcome model is
assumed; fitting A.7 by weighted least squares is simply a convenient way to compute the Hajek
estimator using standard software.
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A.2.2.3 Parametric g-formula
In this final approach, the following altered version of the initial linear regression model was
fit to the data.





where L̃ “ pL´ τq and τ is a vector of constants of length J , and θg2, θg3 are parameter vectors of
length J . This model differs from model A.4 in two key ways: all first order interactions between
A and the covariates L have been added, and all covariates L have been centered at τ . Since the
ATT was of primary interest here, τ was chosen to equal the means of the covariates L among
the exposed, ErL|A “ 1s. Since the true means are unknown, a consistent estimate for τ was




iAi. If interested in the ATE instead, let τ “ ErLs and
consistently estimate using τ̂ “
ř
i Li{n.
The model was then fit using OLS to obtain the estimated ATTg, θ̂g1. This estimator is equiv-
alent to the Snowden et al. (2010) estimator and is consistent for ATTg; see Appendix A.1.
A.2.3 Standard Error Estimators for Each Method
The standard error for the exposure effect estimator from the linear regression model was ob-
tained using the estimated variance matrix resulting from fitting the model with OLS, in keeping
with the conventional approach. Estimating equations were used to compute the standard error
of both the IPW Hajek estimator and the parametric g-formula estimator (Stefanski and Boos,
2002).
When taking an estimating equations approach to computing the standard errors, for IPW
one must decide whether or not to take the estimation of the weights into account. The variance
estimator that results from treating the weights as known is referred to here as the robust sand-
wich variance estimator (robust SVE). Computing the robust SVE is readily accomplished using
various R packages such as sandwich or geepack. Accounting for the weight estimation in the
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variance computation, on the other hand, can be accomplished through supplying the set of esti-
mating equations to the geex package (Saul and Hudgens, 2020) in R.
When using IPW and the ATE is of interest, the robust SVE is conservative when the weights
are assumed known and consistent when weight estimation is taken into account (Lunceford and
Davidian, 2004). If using IPW to estimate the ATT, it is known from the theory of M-estimation
(Stefanski and Boos, 2002) that this variance estimator is consistent when weight estimation
is taken into account; however, it can be either conservative or anti-conservative when weights
are assumed fixed. If computing the standard errors with geex, the set of estimating equations
needed include the score equations from the logistic regression model in A.5 along with the two
estimating equations corresponding to the two pieces of the Hajek estimator.
Bootstrapping is commonly employed to estimate standard errors when the g-formula is
used to estimate the ATE or ATT (Efron and Tibshirani, 1986; Snowden et al., 2010; Wang et al.,
2017), which is a valid option, but using stacked estimating equations provides a closed-form
alternative. It is recommended when using the estimating equations approach that the covariate
mean estimation be taken into account; again, by estimating equation theory, these standard
errors are consistent and yield valid confidence intervals. If using geex to compute the standard
errors for this estimator, the set of estimating equations needed are those corresponding to the
estimation of each covariate mean and the parameters in model A.8.
In the simulations and data analyses of the paper, the variance of the IPW estimator for
ATTg was estimated both ways and the two estimates were found to be fairly different in some
instances and nearly identical in others. The same approach was taken for the variance of the
g-formula estimator for ATTg, and the standard errors were substantially larger when accounting
for estimation of covariate means. The standard error estimates reported were computed taking
into account the estimation of the weights and the covariate means. The R markdown workflow
that accompanies this paper includes code for computing the variance using stacked estimating
equations for both IPW and the g-formula.
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The standard errors for all methods were used to construct Wald 95% confidence intervals
and perform t-tests of H0 : θg1 “ 0, i.e., no effect of exposure on gene expression in the exposed
for gene g.
A.2.4 Assumptions
With all methods presented here, it is assumed the gene expression data have already been
normalized and reduced to one observation per person per gene (i.e., not probe-level data). These
methods also require that there are no missing values; if missing values are present in the covari-
ates L or exposure A, see the recommendations in the section above. For these methods to yield
consistent estimates, it is also assumed that there is no bias due to selection or systematic mea-
surement error. Importantly, formal arguments for IPW and the parametric g-formula estimators
involve asymptotic justifications, and there is no guarantee that these methods will perform well
for small or moderate sample sizes (e.g., n ă 40 for IPW (Pirracchio et al., 2012)).
In order for the IPW and g-formula methods to adequately adjust for confounding, the set
of covariates L must satisfy the conditional exchangeability assumption (Y ag K A|L). It is also
required that positivity P pA “ a|L “ lq ą 0 for all l where dFLplq ą 0 and FL is the CDF
of L, and the Stable Unit Treatment Value Assumption (SUTVA) hold. SUTVA requires causal
consistency, i.e., no different versions of exposure, and no interference, i.e., one individual’s
exposure status doesn’t affect another individual’s gene expression.
For the IPW and g-formula estimators to yield consistent effect estimates, the above assump-
tions must hold. When using IPW, the additional assumption that the model of A|L is correctly
specified is needed as well. For the g-formula, no specification of a model for A|L is needed, but
the model for Yg|A,L must be correctly specified.
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A.3 Supplementary Results
A.3.1 Simulation Study for Ordinary vs Moderated t Statistic
In observational genomics studies, the total sample size is often large enough for results
depending on large sample theory to hold. The limma package (Smyth, 2004) is used in stan-
dard practice to obtain effect estimates, t-statistics, and p-values for each gene when assessing
the effect of some exposure on gene expression. This package computes a moderated t-statistic
that is shown to perform well in small sample sizes, as are found in traditional genetic studies,
and which converges to the ordinary t-statistic as the sample size increases. The moderation of
this t-statistic comes into play with empirical Bayes moderation of the standard errors toward a
common value; here it is shown empirically that these moderated standard errors are practically
equivalent to the ordinary standard errors in large samples.
In Figure A.1 the difference between the moderated and ordinary t-statistics for an example
gene are given for a variety of sample sizes, and with balanced and unbalanced group assignment.
In particular, a randomly chosen gene from the METSIM cohort data was used, and the 770 par-
ticipants were randomly sampled according to their current smoking status to create the analysis
datasets. For each combination of sample size and group allocation, 200 analysis datasets were
constructed. Samples were drawn such that the same individual may have been represented in
more than one dataset, but not more than once within a single dataset. Both types of t-statistic
and their difference were computed for each dataset, and boxplots of the 200 differences are
given for each scenario in Figure A.1. Regardless of the group allocation, once the total sample
size was around 100 or larger, the moderated and ordinary t-statistics were practically equivalent.
All analyses in this paper were conducted with well over 100 individuals, and so ordinary
linear regression was used for simplicity.
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(a) Balanced group sizes (1:1) (b) Unbalanced group sizes (5:1)
Figure A.1: Difference between the moderated and ordinary t-statistics for various sample sizes
with (a) balanced (1 non-smoker : 1 smoker) and (b) unbalanced groups (5 non-smokers : 1
smoker). The boxplot for each sample size represented in (a) and (b) summarizes the difference
in t-statistics for 200 datasets, each derived from the same gene.
A.3.2 Analyses Using Regression Model with Interactions
In the main text, the traditional regression model was constructed without any interaction
terms. This section presents results of the simulation studies designed in the main text and the
METSIM analysis using the regression approach with interactions in the model. Specifically, in-
teractions between smoking (smk) and each of alcohol consumption (alc), vegetable consumption
(veg), hobby exercise (hex), and BMI (bmi) were included. These terms were chosen because they
reflect the interactions included in the parametric g-formula approach. Both alc and bmi were
centered at their population mean in the main effects and the respective interaction terms to avoid
collinearity with the intercept, as was done in the traditional regression analysis.
The empirical bias and confidence interval coverage and width for the ATT estimator from
the regression model with interactions are given in Table A.1 below, again averaging over 1000
simulations per scenario. The simulated data sets used were identical to those that were generated
and analyzed in the main text. Comparing the results in Table A.1 to those in Table 3, it is evident
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that both regression estimators showed bias and failed to meet nominal coverage in the presence
of exposure-covariate interactions. That is, the addition of the interaction terms to the regression
model did not counteract the estimator bias for these scenarios, and in fact worsened the bias for
multiple cases. The regression with interactions approach performed well in terms of estimator
bias and CI coverage for the first three scenarios, but the average CI width in these cases greatly
exceeded that for the other methods. Further, the regression model with interactions doesn’t
generally produce consistent marginal exposure effect estimates; the exposure effects estimated
from this model were conditional on the particular values of the confounding variables.
The exposure effect from the regression model with interactions, as reported here, is inter-
preted as the effect of smoking on gene expression for an individual with alcohol consumption
and BMI equal to the mean in the sample, who doesn’t consume vegetables everyday, and who
has an undefined hobby exercise level (i.e., hex = 0). As mentioned in the Supplementary Meth-
ods, this exposure effect estimate doesn’t necessarily describe any observed individual in the
population. Ultimately, obtaining one marginal estimate to describe a population is desirable
for many researchers, and the conditional estimates produced by the model with interactions are
not readily combined to produce a marginal estimate. There are multiple confounding variables,
some of which are continuous, resulting in an unwieldy number of conditional estimates to work
with.
Table A.1: Average empirical bias, 95% confidence interval coverage, and average width for the
regression with interactions estimator.
Scenario True ATT Estimate Bias 95% CI Coverage 95% CI Width
Null Case 0.00 0.00 0.95 0.33
No Interactions 1 -2.00 -0.01 0.95 0.33
No Interactions 2 2.00 0.06 0.93 0.51
Interactions 1 1.59 0.36 0.09 0.36
Interactions 2 -0.36 2.41 0.00 0.37
Interactions 3 -1.75 3.75 0.00 0.33
When fit using the METSIM data, the regression model with interactions returned the same
top two genes as ranked by p-value, but the smoking effect estimates and SEs were strikingly
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different from the other estimators. In particular, the smoking effect estimates for the top two
genes, CYP1A1 and CYP1B1 were, respectively, 2.81 and 0.99. Both smoking effect estimates
were substantially larger than the estimates produced by the other three methods (from Figure 1:
approximately 2.1 and 0.75 for CYP1A1 and CYP1B1, respectively). The SE estimates for these
top two genes (0.20 and 0.16, respectively) were approximately three times larger than the SE
estimates produced by the regression model without interactions. This result is in accordance
with those shown above for the simulation studies.
A.3.3 Root Mean Square Error for Simulation Study Results
To further examine the bias-variance trade-off of the ATT estimators, the root mean square
error (RMSE) was calculated over the 1000 simulated datasets from the main text and the results
are given in Table A.2. In every scenario considered, the estimator from the regression model
with interactions had the highest RMSE; this is not surprising given the bias and CI width results
presented in Table A.1. With the exception of the Interactions 3 scenario, the RMSE for the IPW
and g-formula estimators were very close. The only scenario considered here where the estimator
from the traditional regression model had RMSE clearly lower than both IPW and the g-formula
was Interactions 3, but the g-formula RMSE was only slightly larger.
Table A.2: Root Mean Square Error for the regression, IPW, parametric g-formula, and
regression with interactions ATT estimators.
Scenario Reg IPW G-form Reg ` Int
Null Case 0.024 0.027 0.025 0.083
No Interactions 1 0.138 0.099 0.098 0.381
No Interactions 2 0.229 0.128 0.128 2.412
Interactions 1 0.253 0.177 0.178 3.754
Interactions 2 0.025 0.031 0.025 0.086
Interactions 3 0.045 0.136 0.050 0.144
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A.3.4 Sensitivity Analyses of METSIM Microarray Data
As mentioned in the main text, there was one large IP weight from the METSIM primary
analysis whose influence deserves further investigation. Deleting this individual from the data
resulted in a sample of size 769, which was analyzed again in the same manner as above. Results
of the regression, IPW, and g-formula sensitivity analysis are compared to the results from the
primary analysis in Figure A.2a - A.2c.
Additionally, the leverage values for each individual were computed from the design matrices
of the g-formula and regression methods. The individual with highest leverage value was the
same for both methods, and another sensitivity analysis was performed by deleting this individ-
ual; the results of this second sensitivity analysis are compared to the results from the primary
analysis in Figure A.2d - A.2f. Notably, the individual with second highest leverage value was the
same individual who generated the largest weight and who was deleted in the sensitivity analysis
above. The genes represented in this figure are the same set as those in Figure 1, namely the top
50 genes as ranked in the primary analysis.
In particular, the first row of this figure shows the deletion of the observation with largest
weight had very little effect on the regression and g-formula estimates, standard errors, and p-
values. On the other hand IPW appears to be more sensitive to the deletion of this observation,
with percent difference in effect estimates and standard errors ranging up to a magnitude of 30
and 25 respectively. These changes were reflected in the ´ log10 adjusted p-values as well; the
bulk of the IPW p-values did not change by more than a magnitude of 50 percent, but p-values
for some estimates changed by more than a magnitude of 300 percent. While the effect on the
majority of the IPW estimates, standard errors, and p-values was small, some of the top 50 genes
saw substantial changes.
For the second sensitivity analysis where the observation with largest leverage value was
deleted, the g-formula and IPW estimates were affected similarly (p´8, 6q percent difference)
and to a slightly larger degree than the regression estimates (p´2, 3q percent difference). The
change in standard errors was largest again for IPW but still contained to p´1, 5q percent differ-
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ence, much smaller than for the previous sensitivity analysis. The change in g-formula standard
errors was contained to p´1, 2q percent difference, and the regression standard errors changed
by less than one percent in either direction. These changes were reflected in the ´ log10 adjusted
p-values as well, with the percent difference for the regression and g-formula p-values having a
spread comparable to the previous sensitivity analysis, and with the IPW p-values being consider-
ably less variable than before.
Sensitivity Analysis 1: Delete Observation with Largest IP Weight
(a) Percent Difference in Estimates (b) Percent Difference in Standard
Errors
(c) Percent Difference in ´ log10
adjusted p-value
Sensitivity Analysis 2: Delete Observation with Largest Leverage Value
(d) Percent Difference in Estimates (e) Percent Difference in Standard
Errors
(f) Percent Difference in ´ log10
adjusted p-value
Figure A.2: (a)-(c): Comparison of METSIM primary and sensitivity analysis results when
deleting observation with largest weight. Top 50 genes are represented, ranked by p-value. (a),
(b), and (c) respectively show the percent difference (primary - sensitivity) of the effect estimates,
standard errors, and ´ log10 Benjamini-Hochberg adjusted p-values. (d)-(f): Comparison of
METSIM primary and sensitivity analysis results when deleting observation with largest leverage
value, which was the same observation for both the regression and g-formula methods. Top 50
genes are represented, ranked by p-value. (d), (e), and (f) respectively show the percent difference
(primary - sensitivity) of the effect estimates, standard errors, and ´ log10 Benjamini-Hochberg
adjusted p-values. R = Regression, W = Inverse Probability Weighting, G = Parametric
G-Formula.
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APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 3
B.1 IPW ATT Estimator Asymptotic Variance
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where in general 0mˆn denotes an mˆ n zero matrix and 0m denotes a column vector of m zeros.
Note that ψα “ pψα0 , ψ
T
α1
q and ψα0 , ψα1 correspond to the score functions for the intercept and
















where a11 is assumed invertible. Since Ai are Bernoulli, which is in the exponential family, a11 “
















































11 p´a21 ` b21q
T




1 tpa21 ´ b21qa
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By the Delta method, Σ “ ∇gpξqTV pξq∇gpξq where ∇gpξqT “ p0, 0TJ , 1,´1q. Let c be the
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u ` EtpY 0i ´ µ0q
2hpLi;αqepLi;αqu ` c11 ` c22 ´ c12 ´ c21
‰
“ Σ˚ ` p´21 pc11 ` c22 ´ 2c12q
where the last equality follows from (3.5) and c12 “ c21 because V pξq is a variance-covariance

















EtAipYi ´ µ1qp1´ epLi;αqqu EtAipYi ´ µ1qp1´ epLi;αqqL
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ErAipYi ´ µ1qt1´ epLi;αqup1, L
T
i qs
























































































Assume the propensity score model (3.1). Using the conditional exchangeability and consis-
tency assumptions, the expectations above can be expressed
























and Etm0hpLi;αqXiu “ ELtEY 0|LpY 0i ´ µ0q P pAi “ 1|Liq
2p1, LTi qu, the latter two of which can
be combined to yield E rm0t1` hpLi;αquXis “ ELtEY 0|LpY 0i ´ µ0q P pAi “ 1|Liqp1, L
T
i qu.
Likewise, a´111 “ b
´1























T . The elements of this matrix can
be expressed
Epψ2α0q “ EtAi ´ 2AiP pAi “ 1|Liq ` P pAi “ 1|Liq
2
u
“ ELrP pAi “ 1|Liqt1´ P pAi “ 1|Liqus




q “ ELrP pAi “ 1|Liqt1´ P pAi “ 1|LiquLiL
T
i s.
Finally, the distribution of L is used to evaluate each expectation. Then an explicit value can
be calculated for each element of the c matrix, and thus for Σ. This is done in Section 3.2.3 for a
few example scenarios, demonstrating that Σ˚ can be either larger or smaller than Σ.
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B.2 Expected Value of ATT Weights
The expected value of the weights proposed by Sato and Matsuyama (2003) equals
ErWATTi s “ EA,L
„
Ai ` p1´ Aiq
P pAi “ 1|Liq
P pAi “ 0|Liq

“ p1 ` EL
„
EA|Lp1´ Aiq
P pAi “ 1|Liq
P pAi “ 0|Liq

“ p1 ` EL rP pAi “ 1|Liqs
“ 2p1
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APPENDIX C: TECHNICAL DETAILS FOR CHAPTER 4
C.1 Details of Methods Presented in Section 4.2
C.1.1 Propensity Score Model
The approach described in Wang et al. (2009) is used to estimate the propensity score. As-
sume the logistic regression model logitte1pL;αqu “ hpL;αq where hpL;αq is some function lin-
ear in α, e.g., htL;α “ pα0, α1qu “ α0`α1L. This model implies eapL;αq “ exptahpL;αqu{r1`
expthpL;αqus. The corresponding vector of score functions for this model can be expressed
BhpL;αq{BαtA ´ e1pL;αqu. In order to account for the second stage of sampling, each individ-
ual is weighted using weights S{gpY, L1, Aq. Fitting this model by maximizing the weighted








tA´ e1pL;αqu “ 0. (C.1)
Note that there is complete data for n of the m individuals from the first phase sample (those with
Si “ 1), and the remaining m´ n will not contribute to the sum. The estimating equations vector
























C.1.2 Inverse Probability Weighting
Consider first the case where K “ 1, i.e., Y is binary. Wang et al. (2009) propose the
following inverse probability weighting approach to causal effect estimation in the context of
two-phase outcome-dependent sampling studies. For estimation of the counterfactual means
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µa “ ErY









UapOi; α̂, µaq “ 0
which yields the Hajek-type estimator µ̂a that is consistent for µa, since the vector of estimating
equations for pα, µ1, µ0q is unbiased.
Now consider the multinomial case where K ą 1. Let π “ pπ1, π0q where πa “ pπa1 , ..., π
a
Kq
for a “ 0, 1. For k “ 1, ..., K and a “ 0, 1, the 2K estimating functions for the counterfactual







The vector of estimating functions ψpOi, α, πq for the IPW estimator is built by stacking the
score functions for the propensity score model with the estimating functions for the counterfac-
tual probabilities.



























































































The estimator pα̂, π̂q that solves
ř
i ψpOi;α, πq “ 0 is consistent for pα, πq and asymptot-
ically normal because the estimating equations vector is unbiased. This was demonstrated in
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The proof for Uk,0pOi;α, πq is analogous.
In terms of the parameters from model (4.1) and the propensity score model from Section
C.1.1, which can be fit by maximizing their weighted likelihoods, we have the following vector
of estimating functions
















































where pα̂, β̂˚q is a solution to the unbiased estimating equations vector
ř
i ψpOi;α, βq “ 0 and is
therefore consistent and asymptotically normal.
C.1.3 Taylor Series Variance Estimator
As in the main text, let 0 be the reference category for the multinomial outcome variable Y .
Now let πhijk represent the probability of developing outcome subtype k where h “ 1, ..., H is
the stratum index, i “ 1, ..., nh is the cluster index within stratum h, and j “ 1, ...,mhi is the unit
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“ Xhijγk, k “ 1, ..., K
where γk “ pγk1, ..., γkpqT and θ “ pγT1 , ..., γ
T
p q
T . The Taylor Series (TS) variance estimator















































and Dhij is the matrix of partial derivatives of the function g with respect to θ where gpXhij, θq “
πhij , whij is a scalar weight, fh is the sampling rate for stratum h, and Y¯ hij
is the column vector
of length K whose elements are indicator variables for the categories 1, ..., K of variable Y. Let
π̂hij “ pπ̂hij1, ..., π̂hijKq
T where π̂hijk “ exppXhij γ̂kq{t1`
řK
q“1 exppXhij γ̂qqu. D̂hij and π̂hij are
evaluated at the MLE θ̂.
This TS variance estimator is commonly used for complex survey data, and the formula
can be simplified for the purposes of this manuscript. In particular, for n i.i.d. individuals let
H “ 1 so there is only one stratum, let fh “ 1{n, and let each individual i represent their
own cluster such that nh “ n and mhi “ 1. Under these conditions, each component may be
expressed without the subscripts h and j. Noting that D̂i “ XTi b pdiagtπ̂iu ´ π̂iπ̂
T
i q, we have
ehi¨ “ ei “ wiX
T
i bpY¯ i
´ π̂iq which represents the score function vector of length pˆK evaluated
at θ̂. This score function vector is also the mean zero estimating function vector for the model
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parameters, evaluated at θ̂. Then ēh¨¨ “ ē “ 1n
řn





















Now note the summand in ´Q̂ is equal to the derivative of the score function vector, evaluated
at θ̂. The summand in Ĝ is equal to the outer product of the score function vector, evaluated at θ̂.
Thus V̂ pθ̂q is proportional to the Huber-White (HW) robust sandwich variance estimator V̂ pθ̂qHW .
Specifically, V̂ pθ̂q “ pn ´ 1q{pn ´ pqV̂ pθ̂qHW . If fitting the multinomial models presented in
Section 4.2 using the SURVEYLOGISTIC procedure in SAS, the option VADJUST=NONE may
be used in the MODEL statement to suppress the adjustment factor pn ´ 1q{pn ´ pq and the TS
variance estimator will be equivalent to the HW estimator.
C.1.4 Regression with Sampling Weights
Let Y be multinomial taking values k “ 0, ..., K, K ą 1, and X is defined as in the main
text. Fitting model (4.4) from the main text by maximizing the weighted likelihood with weights
equal to Si{gpYi, L1i, Aiq yields the estimator λ̂˚ “ pλ̂˚1 , ..., λ̂
˚
Kq, where λ̂













Xi “ 0, k “ 1, ..., K
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This estimating equations vector is unbiased, as shown below, and so λ̂˚ is a consistent and






































since EY |A,LpYkq “ EY |XpYkq “ P pY “ k|Xq and P pY “ k|Xq “ exp pXλkq{t1 `
řK
j“1 exp pXλjqu from model (4.2) in the main text.
C.1.5 Regression with Offsets
Consider first the case where Y is binary and X is defined as in the main text. We wish to
estimate the parameters in the following model,
logittP pY “ 1|Xqu “ Xη
but we have a biased sample and cannot fit this model directly. Weinberg and Wacholder (1990)
propose the following model that can be fit with the observed data
logittP pY “ 1|S “ 1, Xqu “ Xη˚
where Xη˚ “ Xη ` Xω and Xω is the constant offset term whose coefficient is set to one in
the model. Given this relationship, the maximum likelihood estimator for η can be expressed as
η̂ “ η̂˚ ´ ω, where η̂˚ is the maximum likelihood estimator for η˚ and ω is a known column vector.
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In this way, fitting the model with an offset term results in consistent and asymptotically normal
estimators of the model parameters.















Weinberg and Wacholder (1990) also note that since the offset is a constant in the model, the
variance-covariance matrix is appropriately estimated with no correction required.
Now let Y be multinomial taking values k “ 0, ..., K, K ą 1. This approach is applicable
to the scenario in which selection was performed with respect to the dichotomized outcome;
modification of this approach may be required for study designs in which selection is performed
with respect to individual subtypes.
Assume the model (4.4) from the main text, where Xλ˚k “ Xλk ` Xω and Xω represents




P pY “ k|S “ 1, Xq




P pY “ k, S “ 1|Xq{P pS “ 1|Xq




P pY “ k, S “ 1|Xq




P pY “ k|XqP pS “ 1|Y “ k,Xq




P pY “ k|Xq




P pS “ 1|Y “ k,Xq
P pS “ 1|Y “ 0, Xq
˙
“ Xλk `Xω
for all k “ 1, ..., K. The two expressions are equivalent because P pSi “ 1|Yi “ k,Xiq “ P pSi “
1|Yi “ k, L1i “ l1, Ai “ aq, since it is assumed that S K L2 | Y, L1, A. Applying the same logic
as above for the binary case, fitting model (4.4) by maximizing the likelihood including the offset
term results in consistent and asymptotically normal estimators of the λk from model (4.2).
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C.2 Additional Simulation Study Results
Table C.1 below displays simulation study results for the same scenarios given in Table 4.1
of the main text, but with 10% sampling of first phase observations into second phase.
Table C.1: Average empirical bias and 95% confidence interval (CI) coverage and width for the
regression estimators using offsets (Reg Offset) and sampling weights (Reg Wts), and the IPW
estimator. Variances of these estimators were estimated using the Taylor Series (TS) and
bootstrap (Boot) variance estimators, and for IPW the bootstrap estimator accounting for
propensity score estimation (Boot+PS) is also shown. Results are given for both the subtype
conditional OR for subtype 1 (OR1) and subtype 2 (OR2). Scenarios shown are for 10%
sampling proportion of first phase observations into second phase. Empirical bias values larger
than 0.1 and 95% CI coverage values less than 0.90 are underlined.
Scenario Method Variance Bias Coverage CI Width
Est Method OR1 OR2 OR1 OR2 OR1 OR2
OR1 “ 1.05, IPW Boot+PS 0.00 -0.01 0.96 0.97 0.98 0.44
OR2 “ 1.06, Boot 0.96 0.97 0.99 0.44
No confounding TS 0.96 0.97 0.98 0.44
Reg Wts Boot 0.00 -0.02 0.96 0.97 1.00 0.44
TS 0.96 0.97 0.98 0.44
Reg Offset Boot -0.01 -0.02 0.96 0.96 0.97 0.43
TS 0.96 0.96 0.95 0.43
OR1 “ 0.86, IPW Boot+PS -0.04 0.01 0.93 0.96 0.33 0.33
OR2 “ 0.17, Boot 0.96 0.97 0.37 0.36
Confounding TS 0.97 0.95 0.37 0.27
with interactions Reg Wts Boot 0.21 0.01 0.52 0.97 0.46 0.29
TS 0.51 0.96 0.46 0.27
Reg Offset Boot 0.13 0.03 0.77 0.96 0.43 0.31
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